count,diagnosis,group_name,subgroup_name,male_count,female_count,age_mean,age_median,age_minimum,age_maximum,age_range,imaging_sample,age_mean_female,age_median_female,age_minimum_female,age_maximum_female,pmcid
25.0,healthy,healthy,healthy subjects,18.0,7.0,23.16,23.0,,,,,,,,,5924771
8.0,null,patients,postnatal day 18,8.0,6.0,,,,,null,yes,,,,,6520292
7.0,null,patients,postnatal day 5286,7.0,6.0,,,,,null,yes,,,,,6520292
30.0,healthy,healthy,healthy adults,20.0,10.0,26.0,26.0,21.0,31.0,21-31,yes,,,,,10889874
10749.0,autoimmune diseases,patients,SLE,5379.0,540.0,31.4,28.0,,,,,,,,,6713388
10749.0,autoimmune diseases,patients,non-SLE autoimmune diseases,,,,,,,,,,,,,6713388
11443.0,non-autoimmune diseases,patients,non-autoimmune diseases,,,,,,,,,,,,,6713388
0.0,,healthy,null,,,,,,,,,,,,,5931657
16.0,prostate cancer,patients,prostate tumor specimens,,,,,,,,yes,,,,,4103770
32.0,clinically definite relapsing-remitting MS,patients,MS patients,0.0,32.0,,,,,,,,,,,2813302
21.0,healthy,healthy,healthy controls,0.0,21.0,,,,,,,,,,,2813302
30.0,recurrent UTI,patients,recurrent UTI,0.0,30.0,,,,,,yes,,,,,3655152
10.0,controls,healthy,controls,0.0,10.0,,,,,,yes,,,,,3655152
13.0,active TB,patients,T0,7.0,6.0,,,50.0,58.0,50-58,yes,,,,,2678250
9.0,LTBI,healthy,LTBI,5.0,4.0,,,30.0,45.0,30-45,yes,,,,,2678250
25.0,MDD,patients,MDD patients,,,,,,,,,,,,,9001100
24.0,Healthy Controls,healthy,HCs,,,,,,,,,,,,,9001100
0.0,chronic pain,patients,chronic pain patients,,,,,,,,,,,,,9513358
0.0,healthy,healthy,healthy participants,,,,,,,,,,,,,9513358
110.0,"moderate-to-severe, treatment-resistant depression",patients,treatment-seeking adults,,,,,,,,yes,,,,,8410762
21.0,MDD,patients,"first episode, short duration, untreated",13.0,8.0,,,18.0,56.0,,,,,,,5661170
25.0,healthy,healthy,"matched for age, gender, and education years",,,,,,,,,,,,,5661170
19.0,schizophrenia or schizoaffective disorder,patients,raloxifene trial,,,35.0,,,,null,yes,,,,,4781892
977.0,null,patients,children,525.0,452.0,38.8,38.0,32.0,37.0,32-37,,,,,,8978891
1199.0,null,patients,adults,131.0,1068.0,27.0,,,,null,,,,,,8978891
20.0,Parkinson's Disease,patients,PD,,,,,,,,yes,,,,,6292599
20.0,Healthy Controls,healthy,HC,,,,,,,,yes,,,,,6292599
3.0,null,patients,Macaca mulatta,3.0,0.0,,,,,null,,,,,,4244037
285.0,HGG and LGG,patients,HGG,,,,,,,,,,,,,10796062
285.0,HGG and LGG,patients,LGG,,,,,,,,,,,,,10796062
4.0,CJD,patients,CJD patients,,,,,,,,,,,,,4395093
4.0,AD,patients,AD patients,,,,,,,,,,,,,4395093
4.0,CJD,controls,age-matched controls,,,,,,,,,,,,,4395093
4.0,AD,controls,age-matched controls,,,,,,,,,,,,,4395093
65.0,osteoporosis,patients,osteoporotic,0.0,65.0,,,,,,yes,,,,,10584188
61.0,normal-BMD,patients,normal-BMD,0.0,61.0,,,,,,yes,,,,,10584188
11.0,null,patients,hawksbill turtles,0.0,11.0,,,,,,,,,,,7886132
11.0,null,patients,loggerhead turtles,1.0,10.0,,,,,,,,,,,7886132
1.0,null,patients,green turtle,1.0,0.0,,,,,,,,,,,7886132
539.0,Diabetes Mellitus,patients,Newly diagnosed DM patients,301.0,238.0,46.05,,15.0,120.0,15-120,yes,,,,,9560537
970.0,HIV-positive,patients,Black women,0.0,970.0,,,,,,,,,,,5714351
288.0,HIV-negative,patients,Black women,0.0,288.0,,,,,,,,,,,5714351
6.0,control,healthy,female-control,0.0,6.0,,,,,,yes,,,,,3313971
6.0,cafeteria,patients,female-cafeteria,0.0,6.0,,,,,,yes,,,,,3313971
6.0,control,healthy,male-control,6.0,0.0,,,,,,yes,,,,,3313971
6.0,cafeteria,patients,male-cafeteria,6.0,0.0,,,,,,yes,,,,,3313971
646.0,null,patients,young adults,283.0,363.0,20.08,20.0,16.0,24.0,16-24,,,,,,9942989
7.0,EIH,patients,endurance-trained athletes,7.0,0.0,,,,,,,,,,,5008680
8.0,non-EIH,patients,endurance-trained athletes,8.0,0.0,,,,,,,,,,,5008680
8.0,none,healthy,untrained,,,,,,,,,,,,,5008680
5.0,DSS treatment,patients,FVB-N mice,3.0,2.0,,,,,,,,,,,3411826
2.0,DSS treatment,patients,C57BL6 procollagen 1(I)-GFP reporter mice,2.0,0.0,,,,,,,,,,,3411826
25.0,sporadic PTC,patients,Japanese PTCs,4.0,21.0,53.3,,18.0,81.0,18-81,yes,,,,,3340412
20.0,current car drivers,patients,current drivers,,,68.0,68.0,60.0,79.0,60-79,yes,,,,,7228106
2.0,former car drivers,patients,former drivers,0.0,2.0,,,,,,yes,,,,,7228106
5.0,SAP102 mutant,patients,SAP102,3.0,2.0,,,,,,,,,,,2110885
5.0,wild-type,healthy,SAP102,3.0,2.0,,,,,,,,,,,2110885
4.0,SAP102 mutant,patients,C57BL/6j,2.0,2.0,,,,,,,,,,,2110885
5.0,PSD-95 mutant,patients,hippocampus,3.0,2.0,,,,,,,,,,,2110885
4.0,wild-type,healthy,hippocampus,2.0,2.0,,,,,,,,,,,2110885
2.0,PSD-95 mutant,patients,cortex,1.0,1.0,,,,,,,,,,,2110885
2.0,wild-type,healthy,cortex,1.0,1.0,,,,,,,,,,,2110885
194.0,null,healthy,female healthcare professionals,0.0,194.0,33.14,33.0,21.0,65.0,21-65,,,,,,11008815
70.0,healthy,healthy,Condition 1Human Body Part,,,27.5,,18.0,61.0,18-61,yes,,,,,8292743
70.0,healthy,healthy,Condition 2Animal Body Part,,,27.5,,18.0,61.0,18-61,yes,,,,,8292743
43.0,chronic WAD,patients,chronic WAD,18.0,25.0,39.4,39.0,18.0,65.0,18-65,,,,,,5967697
16.0,asymptomatic controls,healthy,asymptomatic controls,5.0,11.0,38.6,39.0,18.0,65.0,18-65,,,,,,5967697
69.0,Alzheimer Disease,patients,AD,,,,,,,,,,,,,3720883
62.0,Mild Cognitive Impairment,patients,MCI,,,,,,,,,,,,,3720883
68.0,Cognitively Normal,healthy,NC,,,,,,,,,,,,,3720883
9.0,"AN, BN, Other Specified Feeding or Eating Disorder",patients,Eating Disorder Patients,0.0,9.0,26.6,25.0,19.0,43.0,19-43,,,,,,7890966
997.0,breast cancer,patients,discovery,,,,,,,,,,,,,4488510
989.0,breast cancer,patients,validation,,,,,,,,,,,,,4488510
1570.0,breast cancer,patients,ROCK,,,,,,,,,,,,,4488510
6.0,null,patients,ADSCs,0.0,6.0,,,29.0,37.0,,,,,,,3789739
7.0,ATTR-CA,patients,positive Tc-PYP,7.0,0.0,,,,,,,,,,,8270434
0.0,,healthy,rBA,,,,,,,,,,,,,4954705
16.0,healthy,healthy,participants,7.0,9.0,26.6,,20.0,38.0,20-38,yes,,,,,4989013
36.0,null,patients,CB6F1 mice,18.0,18.0,20.0,20.0,20.0,20.0,20-20,yes,,,,,6043711
105.0,tumors,patients,SCA,,,,,,,,,,,,,4664485
59.0,no tumors,healthy,SCI,,,,,,,,,,,,,4664485
89.0,no tumors,healthy,SNI,,,,,,,,,,,,,4664485
9.0,experimental,patients,C57BL/6 WT mice,9.0,0.0,31.0,31.0,31.0,31.0,31-31,,,,,,6169940
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,6016802
166.0,not specified,patients,not specified,67.0,99.0,66.5,,41.0,93.0,41-93,yes,,,,,8136703
80.0,Alzheimers disease,patients,AD,,,,,,,,yes,,,,,9211045
80.0,healthy controls,healthy,HC,,,,,,,,yes,,,,,9211045
269999.0,medical and surgical admissions,patients,Churpek et al.,,,60.0,,,,null,yes,,,,,6333367
44531.0,medical admissions,patients,Kellett et al.,,,67.5,,,,null,yes,,,,,6333367
2.0,BRAF mutant melanoma,patients,M397,,,,,,,,yes,,,,,6576794
2.0,BRAF mutant melanoma,patients,M229,,,,,,,,yes,,,,,6576794
30.0,healthy,healthy,controls,,,,,,,,yes,,,,,9421442
30.0,neurologically healthy,healthy,volunteers,13.0,17.0,24.72,24.0,21.0,30.0,,yes,,,,,6131631
41.0,null,healthy,trainee teachers,5.0,36.0,23.27,,18.0,35.0,18-35,no,,,,,6594637
12.0,5xFAD,patients,5xFAD Training group,,,,,,,,,,,,,10556575
14.0,WT,healthy,WT Training group,,,,,,,,,,,,,10556575
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,3698143
0.0,null,healthy,null,0.0,0.0,,,,,,,,,,,3698143
15.0,no known neurological or sensory impairments,healthy,participants,9.0,6.0,28.5,28.0,22.0,35.0,22-35,,,,,,10017858
32.0,brain trauma and brain tumors,patients,acquired or congenital brain damage,19.0,13.0,,,,,,yes,,,,,6010294
3.0,Rhizomelic Chondrodysplasia Punctata (RCDP) type 1,patients,Pex7 KO mice,2.0,1.0,,,,,,,,,,,3232224
4.0,healthy,healthy,WT mice,2.0,2.0,,,,,,,,,,,3232224
20.0,null,patients,post-abortion care clients,0.0,20.0,,,,,<20-39,no,,,,,8057598
86.0,lymphoma,patients,all patients,57.0,29.0,58.4,,,,null,yes,,,,,9371255
224.0,chronic pain,patients,ADAPT program,94.0,130.0,,,16.0,91.0,,,,,,,10578420
35.0,healthy,healthy,healthy subjects,16.0,19.0,43.0,43.0,27.0,73.0,27-73,yes,,,,,4511822
0.0,null,patients,LRRK2 (G2019S),,,,,,,null,no,,,,,5094768
0.0,null,healthy,isogenic control,,,,,,,null,no,,,,,5094768
0.0,null,patients,LRRK2 (G2019S) knock-in,,,,,,,null,no,,,,,5094768
91.0,no cardiac shunts or malformations,patients,unknown shunts,56.0,35.0,52.0,52.0,39.0,62.0,39-62,,,,,,7081189
10.0,known cardiac shunt,patients,known shunts,3.0,7.0,44.0,44.0,41.0,47.0,41-47,,,,,,7081189
2971.0,normotensive to stage 2 HTN,patients,discovery population,,,,,,,,yes,,,,,3399862
4620.0,normotensive to stage 2 HTN,patients,replication population,,,,,,,,yes,,,,,3399862
1.0,Tylosaurus proriger,patients,FFHM 199710,,,,,,,,,,,,,4334958
1.0,Platecarpus tympaniticus,patients,LACM 128319,,,,,,,,,,,,,4334958
1.0,Platecarpus tympaniticus,patients,KU 1001,,,,,,,,,,,,,4334958
1.0,Clidastes propython,patients,CFDC M74.10.06,,,,,,,,,,,,,4334958
1.0,"Mosasaurus sp., cf. M. missouriensis",patients,TMP 2012.010.0001,,,,,,,,,,,,,4334958
47.0,none,patients,children,18.0,29.0,,,3.0,10.0,3-10,yes,,,,,6969086
40.0,none,healthy,college students,9.0,31.0,21.2,,18.0,23.0,18-23,yes,,,,,6969086
885.0,PTSS,patients,RISK study participants,0.0,885.0,25.19,,18.0,34.0,18-34,yes,,,,,7577433
31.0,healthy,healthy,adolescents,10.0,21.0,15.5,15.0,12.0,17.0,,yes,,,,,3242169
13.0,DGF or kidney function deterioration,patients,Kidney transplant recipients,8.0,5.0,57.9,,,,unknown,yes,,,,,7237443
59.0,cardiorespiratory admission diagnosis,patients,ICU patients,38.0,21.0,62.0,62.0,53.0,66.0,53-66,yes,,,,,10101425
14.0,NAFLD or steatohepatitis,patients,LAR,14.0,0.0,,,,,,,,,,,6892561
10.0,NAFLD or steatohepatitis,patients,FC,10.0,0.0,,,,,,,,,,,6892561
257.0,probable AD,patients,AD,,,,,,,,,,,,,8044304
71.0,minor neurological non-neurodegenerative disorders,patients,OND,,,,,,,,,,,,,8044304
1752544.0,FQ-related AEs,patients,FQ-related AEs,88999.0,1663545.0,60.8,,,,,,,,,,6485715
0.0,null,patients,Bloodstream form (BSF),,,,,,,null,,,,,,2997783
0.0,null,patients,Procyclic form (PCF),,,,,,,null,,,,,,2997783
26.0,null,patients,null,8.0,18.0,21.9,,,,null,,,,,,10076762
71.0,tinnitus,patients,tinnitus patients,33.0,38.0,,,,,,,,,,,10111057
14.0,healthy,healthy,healthy volunteers,,,,,,,,,,,,,10111057
20.0,healthy,healthy,nocturnal sleep (NS) group,20.0,0.0,23.0,23.0,21.0,28.0,21-28,,,,,,10151529
22.0,healthy,healthy,sleep deprivation (SD) group,22.0,0.0,23.0,23.0,21.0,28.0,21-28,,,,,,10151529
21.0,Tourette syndrome,patients,TS with ADHD,17.0,4.0,10.5,10.0,7.0,15.0,7-15,,,,,,3497583
19.0,nonsmokers,patients,nonsmokers,,,,,,,,,,,,,5347953
19.0,weekly smokers,patients,weekly smokers,,,,,,,,,,,,,5347953
20.0,daily smokers,patients,daily smokers,,,,,,,,,,,,,5347953
21.0,none,patients,NpHR experimental group,21.0,0.0,,,3.0,4.0,3-4 months,yes,,,,,7481003
22.0,none,patients,eYFP control group,22.0,0.0,,,3.0,4.0,3-4 months,yes,,,,,7481003
56.0,healthy,healthy,social judgement,,,,,,,,,,,,,10532823
17.0,healthy,healthy,moral judgement,,,,,,,,,,,,,10532823
11.0,healthy,healthy,risk judgement,,,,,,,,,,,,,10532823
8.0,healthy,healthy,interpersonal judgement,,,,,,,,,,,,,10532823
24.0,none,patients,6-month-old NEP-knockout mice,24.0,0.0,6.0,6.0,6.0,6.0,6-6,yes,,,,,2643003
12.0,none,patients,21-month-old NEP-knockout mice,12.0,0.0,21.0,21.0,21.0,21.0,21-21,yes,,,,,2643003
12.0,none,patients,21-month-old wild-type mice,9.0,3.0,21.0,21.0,21.0,21.0,21-21,yes,,,,,2643003
9.0,none,patients,21-month-old NEP-knockout mice,9.0,0.0,21.0,21.0,21.0,21.0,21-21,yes,,,,,2643003
0.0,null,patients,MDCK cells,0.0,0.0,,,,,null,,,,,,2359857
163.0,null,healthy,Singapore,46.0,117.0,21.9,,,,null,yes,,,,,8428676
163.0,null,healthy,U.S.,45.0,118.0,21.49,,,,null,yes,,,,,8428676
0.0,null,healthy,V-East,,,,,,,null,,,,,,6776359
0.0,null,healthy,V-West,,,,,,,null,,,,,,6776359
0.0,null,healthy,CV,,,,,,,null,,,,,,6776359
0.0,null,healthy,UV,,,,,,,null,,,,,,6776359
0.0,,healthy,SLFN11-WT,,,,,,,,,,,,,8017720
0.0,,healthy,SLFN11-KO,,,,,,,,,,,,,8017720
67.0,none,healthy,LdLp,,,,,,,,yes,,,,,2972212
67.0,none,healthy,OdLp,,,,,,,,yes,,,,,2972212
67.0,none,healthy,LdOp,,,,,,,,yes,,,,,2972212
67.0,none,healthy,OdOp,,,,,,,,yes,,,,,2972212
85.0,FHR-SZ,patients,FHR-SZ,41.0,44.0,,,,,,,,,,,11059809
63.0,FHR-BP,patients,FHR-BP,30.0,33.0,,,,,,,,,,,11059809
98.0,PBC,healthy,PBC,49.0,49.0,,,,,,,,,,,11059809
340.0,null,patients,US residents,190.0,150.0,35.41,,18.0,74.0,18-74,yes,,,,,5469794
1.0,healthy,healthy,adult healthy men,10.0,0.0,,25.0,20.0,30.0,20-30,yes,,,,,7116965
12.0,non-diabetic control,healthy,non-diabetic control group,12.0,0.0,,,,,8 weeks,yes,,,,,4408020
12.0,non-diabetic control,healthy,non-diabetic control group (K+RSV),12.0,0.0,,,,,8 weeks,yes,,,,,4408020
12.0,diabetic,patients,diabetic group,12.0,0.0,,,,,8 weeks,yes,,,,,4408020
9.0,diabetic,patients,diabetic group treated with resveratrol (D+RSV),9.0,0.0,,,,,8 weeks,yes,,,,,4408020
2.0,null,patients,Monkey K,1.0,1.0,,,,,,,,,,,3528341
2.0,null,patients,Monkey S,1.0,1.0,,,,,,,,,,,3528341
16.0,healthy,patients,6-month-olds,11.0,5.0,6.0,6.0,6.0,6.0,6-6,,,,,,3930744
16.0,healthy,patients,12-month-olds,7.0,9.0,12.0,12.0,12.0,12.0,12-12,,,,,,3930744
16.0,healthy,patients,12-month-olds Experiment 2,8.0,8.0,12.0,12.0,12.0,12.0,12-12,,,,,,3930744
30.0,StD,patients,StD subjects,19.0,11.0,,,,,,,,,,,10113366
61.0,HCs,healthy,healthy controls,32.0,29.0,,,,,,,,,,,10113366
6.0,hypertensive cardiac disease,patients,Smad7 KO mice,6.0,0.0,,,8.0,10.0,8-10 weeks,yes,,,,,3720917
10.0,null,patients,CLCF1-ATG,10.0,0.0,8.0,8.0,8.0,8.0,8-8,yes,,,,,10433725
335.0,mumps,patients,mumps outbreak,225.0,110.0,21.6,,4.0,58.0,4-58,no,,,,,4619890
157.0,DILI,patients,DILI cases,96.0,61.0,46.0,46.0,19.0,91.0,19-91,yes,,,,,10231779
634.0,No DILI,patients,controls,362.0,272.0,37.0,37.0,0.0,93.0,0-93,yes,,,,,10231779
100.0,null,patients,male SpragueDawely rats,100.0,0.0,,,,,null,,,,,,6093657
11332.0,ASD symptoms,patients,Class 1,5776.0,5522.0,18.55,18.0,18.0,19.0,,yes,,,,,3536994
11332.0,ASD symptoms,patients,Class 2,5776.0,5522.0,18.55,18.0,18.0,19.0,,yes,,,,,3536994
11332.0,ASD symptoms,patients,Class 3,5776.0,5522.0,18.55,18.0,18.0,19.0,,yes,,,,,3536994
11332.0,ASD symptoms,patients,Class 4,5776.0,5522.0,18.55,18.0,18.0,19.0,,yes,,,,,3536994
100.0,AS,patients,first stage,79.0,21.0,29.5,29.0,21.0,45.0,21-45,,,,,,5426703
100.0,healthy,healthy,first stage,80.0,20.0,29.91,29.0,20.0,40.0,20-40,,,,,,5426703
620.0,AS,patients,second stage,515.0,105.0,28.28,28.0,18.0,50.0,18-50,,,,,,5426703
620.0,healthy,healthy,second stage,512.0,108.0,27.83,27.0,19.0,45.0,19-45,,,,,,5426703
11.0,cancer septic,patients,cancer,,,,,,,,,,,,,5770055
11.0,previously healthy septic,healthy,healthy,,,,,,,,,,,,,5770055
6.0,hepatotoxicity,patients,nimesulide treated,6.0,0.0,,,12.0,18.0,12-18,yes,,,,,3317927
30.0,healthy,healthy,young adults,8.0,22.0,23.9,23.0,16.0,40.0,16-40,,,,,,8963905
11408.0,malaria,patients,neonates,5974.0,5434.0,,,,,,yes,,,,,6988973
0.0,null,patients,null,,,,,,,,,,,,,11101039
43.0,null,patients,experts,,,,,,,,,,,,,9889848
36.0,severe renal dysfunction,patients,se-RD,26.0,10.0,60.9,60.0,,,,,,,,,9427930
85.0,moderate renal dysfunction,patients,mo-RD,57.0,28.0,62.3,62.0,,,,,,,,,9427930
45.0,control group,healthy,CG,19.0,26.0,43.7,43.0,,,,,,,,,9427930
8.0,null,patients,ponies,5.0,3.0,14.0,14.0,14.0,15.0,14-2.8,,,,,,6025858
64.0,null,healthy,psychology students,12.0,52.0,18.69,18.0,18.0,26.0,18-26,,,,,,4503786
64.0,null,patients,null,,,,,,,,,,,,,4503786
45.0,naive participants,healthy,participants,27.0,18.0,25.0,25.0,18.0,32.0,18-32,,,,,,10614914
149.0,healthy,healthy,overall,62.0,87.0,23.0,19.0,17.0,63.0,17-63,yes,,,,,5120109
53.0,spastic type of CP,patients,BTX-A treatment,,,,,,,,yes,,,,,4816309
58.0,PLWHIV,patients,PLWHIV_1,,,,,,,,yes,,,,,7561185
58.0,PLWHIV,patients,PLWHIV_2,,,,,,,,yes,,,,,7561185
58.0,PLWHIV,patients,PLWHIV_3,,,,,,,,yes,,,,,7561185
13.0,Cerebral Palsy,patients,spastic diplegic,8.0,5.0,15.53,15.0,,,,,,,,,5440753
15.0,Typically Developing,healthy,typically developing,8.0,7.0,14.13,14.0,,,,,,,,,5440753
184.0,cognitively normal,healthy,whole sample,,,,,,,,yes,,,,,5710531
15.0,Fibromyalgia,patients,FM,1.0,14.0,,45.0,,,null,,,,,,11140151
18.0,Healthy controls,healthy,CTRL,1.0,17.0,,38.0,,,null,,,,,,11140151
15.0,ADHD,patients,spinal manipulation first,,,,,,,,yes,,,,,8394036
15.0,ADHD,patients,control first,,,,,,,,yes,,,,,8394036
0.0,,healthy,C. sapidus,0.0,0.0,,,,,,,,,,,4388526
82.0,non-obese,patients,non-obese,,,40.44,,19.0,30.0,19.5-30,yes,,,,,5338794
62.0,obese,patients,obese,,,47.19,,30.0,40.0,30-40,yes,,,,,5338794
34.0,Type 2 diabetes mellitus (T2DM),patients,T2DM patients,,,,,,,,,,,,,7303156
88.0,healthy,healthy,healthy controls,,,,,,,,,,,,,7303156
195.0,COVID-19 viral pneumonia,patients,Montreal-COVID-19 CXR dataset,131.0,64.0,,,,,,,,,,,7660555
134.0,COVID-19 viral pneumonia,patients,Twitter-COVID-19 CXR dataset,,,,,,,,,,,,,7660555
16.0,T1D,patients,Std-GCC,8.0,8.0,,,,,,,,,,,3827256
19.0,T1D,patients,C-GFC,8.0,11.0,,,,,,,,,,,3827256
19.0,T1D,patients,EW-GFC,9.0,10.0,,,,,,,,,,,3827256
23.0,T1D,patients,GS-GFC,,,,,,,,,,,,,3827256
6.0,brachial plexus avulsion,patients,patients with brachial plexus avulsion,5.0,1.0,,,26.0,47.0,,,,,,,6305497
12.0,healthy,healthy,healthy controls,,,,,,,,,,,,,6305497
158.0,TPE,patients,TPE,,,45.0,,,,<40-<40,yes,,,,,8202948
400.0,mild-to-moderate AD,patients,DHA trial,188.0,212.0,75.6,,,,null,yes,,,,,3031880
12.0,null,patients,ORG,6.0,6.0,,,,,null,,,,,,6957345
1618.0,null,patients,young men,1618.0,0.0,,,15.0,24.0,15-24,yes,,,,,7853509
2574.0,null,patients,young women,0.0,2574.0,,,15.0,24.0,15-24,yes,,,,,7853509
1702.0,null,patients,young men,1702.0,0.0,,,15.0,24.0,15-24,yes,,,,,7853509
2461.0,null,patients,young women,0.0,2461.0,,,15.0,24.0,15-24,yes,,,,,7853509
671.0,null,patients,young men,671.0,0.0,,,15.0,24.0,15-24,yes,,,,,7853509
2321.0,null,patients,young women,0.0,2321.0,,,15.0,24.0,15-24,yes,,,,,7853509
166.0,severe AECOPD,patients,pre-pandemic,,,,,,,,,,,,,10501653
174.0,severe AECOPD,patients,pandemic,,,,,,,,,,,,,10501653
87.0,severe AECOPD,patients,pre-vaccination,,,,,,,,,,,,,10501653
152.0,knee osteoarthritis,patients,working TKA patients,,,55.0,,28.0,63.0,28-63,yes,,,,,5571908
523.0,knee osteoarthritis,patients,retired TKA patients,,,74.0,,65.0,91.0,65-91,yes,,,,,5571908
716.0,Meniere's disease,patients,unilateral and bilateral MD,,,,,,,,yes,,,,,4232390
17.0,family history of major depression,patients,FH,3.0,14.0,17.6,17.0,16.0,20.0,16-20,,,,,,2890050
15.0,no history of major depression,healthy,HC,4.0,11.0,18.9,19.0,17.0,21.0,17-21,,,,,,2890050
12.0,AP,patients,"AP, probiotics",,,,,,,,,,,,,2639703
12.0,AP,patients,"AP, placebo",,,,,,,,,,,,,2639703
12.0,sham-procedure,patients,sham,,,,,,,,,,,,,2639703
5.0,non-operated controls,patients,control,,,,,,,,,,,,,2639703
64.0,nonkeratinizing undifferentiated NPC,patients,pre-RT,51.0,13.0,46.0,,22.0,63.0,22-63,yes,,,,,5357686
22.0,nonkeratinizing undifferentiated NPC,patients,post-RT-ED,,,,,,,,yes,,,,,5357686
20.0,nonkeratinizing undifferentiated NPC,patients,post-RT-LD,,,,,,,,yes,,,,,5357686
300.0,Tuberculosis (TB),patients,MDR-TB,196.0,104.0,30.0,30.0,15.0,85.0,15-85,yes,,,,,7428183
24.0,null,healthy,participants,11.0,13.0,27.3,27.0,24.0,30.0,24-30,yes,,,,,6602963
0.0,null,patients,DA neurons,,,,,,,null,yes,,,,,3530538
959.0,none,healthy,overall,351.0,606.0,68.34,68.0,50.0,93.0,50-93,,,,,,7449056
436.0,none,healthy,CBS participants,163.0,272.0,67.14,67.0,50.0,90.0,50-90,,,,,,7449056
17.0,rectal cancer,patients,rectal cancer patients,16.0,1.0,68.65,71.0,51.0,76.0,,,,,,,5400638
39.0,control,patients,Ahi1+/+,39.0,0.0,9.0,9.0,9.0,9.0,9-9,yes,,,,,6028478
34.0,CUS,patients,Ahi1+/,34.0,0.0,9.0,9.0,9.0,9.0,9-9,yes,,,,,6028478
28.0,glioma,patients,recurrent tumors,,,,,,,,,,,,,7527584
28.0,glioma,patients,newly diagnosed tumors,,,,,,,,,,,,,7527584
59.0,null,healthy,rice genotypes,,,,,,,null,no,,,,,5983461
57.0,healthy,healthy,healthy volunteers,,,,,,,,yes,,,,,4226573
133.0,cardiovascular disease,patients,cardiovascular disease subjects,105.0,85.0,,,18.0,75.0,18-75,yes,,,,,4226573
21.0,healthy,healthy,participants,2.0,19.0,,,,,,yes,,,,,6854468
62.0,null,patients,Hispanic children,29.0,33.0,8.7,8.0,7.0,10.0,7-10,,,,,,7714231
323.0,Bullied,patients,Bullied,198.0,125.0,9.88,10.0,9.0,10.0,9-10,yes,,,,,10163612
322.0,Non-bullied,healthy,Non-bullied,171.0,132.0,9.84,10.0,9.0,10.0,9-10,yes,,,,,10163612
1919.0,none,patients,police intervention,,,,,,,,yes,,,,,10931527
2.0,null,patients,Rhesus macaque monkeys,2.0,0.0,,,,,null,yes,,,,,9882082
16.0,"schizophrenia, anorexia nervosa, attention deficit hyperactivity disorder, mood disorder",patients,patients with psychiatric disorders,,,,,11.0,41.0,11-41,yes,,,,,8886766
1511.0,NDMM-TI,patients,1LOT,,,71.3,,,,null,yes,,,,,8153459
50.0,healthy,healthy,young adults,25.0,25.0,22.0,22.0,18.0,30.0,18-30,yes,,,,,4172636
30.0,patients,patients,older adults,15.0,15.0,65.0,65.0,60.0,75.0,60-75,yes,,,,,4172636
240.0,undiagnosed pleural effusions,patients,MPM,,,,,,,,yes,,,,,5624636
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,3812127
118.0,tuberculosis treatment dropout,patients,dropout cases,,,,,,,,yes,,,,,6133354
360.0,tuberculosis cure,patients,controls,,,40.6,,,,unknown,yes,,,,,6133354
34.0,none,patients,contact athletes,34.0,0.0,14.7,14.0,10.0,18.0,10-18,,,,,,10666028
23.0,none,patients,non-contact athletes,0.0,23.0,,,,,,,,,,,10666028
4900.0,chemotherapy,patients,newer antiemetic agents,,,,,,,,,,,,,2912767
19000.0,chronic heart failure,patients,ACE-inhibitors,,,,,,,,,,,,,2912767
3500.0,major depressive disorder,patients,second-generation antidepressants,,,,,,,,,,,,,2912767
12.0,,healthy,mice,,,,,,,,,,,,,9250522
6.0,,healthy,mice,,,,,,,,,,,,,9250522
0.0,,healthy,RPE-1 cells,,,,,,,,,,,,,2586089
0.0,,healthy,U2OS cells,,,,,,,,,,,,,2586089
43.0,chronic low-back pain (CLBP),patients,CLBP,17.0,26.0,,,,,,yes,,,,,8830732
51.0,subacute back pain (SBP),patients,SBP,31.0,20.0,,,,,,yes,,,,,8830732
36.0,healthy controls,healthy,HC,20.0,16.0,,,,,,yes,,,,,8830732
0.0,null,patients,Iso-2.1,,,,,,,null,no,,,,,2866655
0.0,null,patients,Iso-3.1,,,,,,,null,no,,,,,2866655
41.0,Parkinsons disease,patients,overall,25.0,16.0,61.7,61.0,54.0,69.0,54-69,,,,,,5766081
11.0,advanced pancreatic cancer,patients,Group A,,,,,,,,,,,,,5242484
10.0,advanced pancreatic cancer,patients,Group B,,,,,,,,,,,,,5242484
54.0,Graves disease,patients,Graves disease patients,,,,,,,,yes,,,,,5886569
47.0,nonfunctional adrenal tumors,healthy,control participants,,,,,,,,yes,,,,,5886569
16.0,healthy,healthy,control,,,,,,,,yes,,,,,10389659
25.0,syringomyelia with chronic neuropathic pain,patients,study,,,,,,,,yes,,,,,10389659
16.0,null,patients,Wistar rats,16.0,0.0,,,,,null,yes,,,,,5362237
614.0,mood disorder symptoms,patients,Saudi participants,104.0,510.0,26.33,,18.0,74.0,18-74,yes,,,,,6705794
0.0,null,patients,null,0.0,0.0,,,,,null,,,,,,5884547
0.0,null,healthy,null,0.0,0.0,,,,,null,,,,,,5884547
17.0,strabismic amblyopia,patients,Group S,,,,,,,,yes,,,,,3916433
11.0,anisometropic amblyopia,patients,Group A,,,,,,,,yes,,,,,3916433
10.0,combined amblyopia (strabismus and anisometropia),patients,Group AS,,,,,,,,yes,,,,,3916433
22.0,healthy,healthy,cyclists,22.0,0.0,,,,,<21,yes,,,,,3184100
22.0,healthy,healthy,controls,22.0,0.0,,,,,<21,yes,,,,,3184100
8.0,none,patients,ferrets,8.0,0.0,,15.0,15.0,,15-15,no,,,,,8559940
1060.0,null,patients,13-19 years,,,15.7,,13.0,19.0,13-19,yes,,,,,7660520
6.0,null,patients,control group,,,,,,,,,,,,,4351252
17.0,null,patients,experimental group,,,,,,,,,,,,,4351252
30.0,SCAD,patients,SCAD survivors,3.0,27.0,52.2,52.0,35.0,71.0,35-71,,,,,,9447895
95.0,Alzheimers disease,patients,AD,51.0,44.0,64.84,64.0,59.0,68.0,59-68,,,,,,9659748
106.0,frontotemporal lobar degeneration,patients,FTLD,45.0,61.0,63.24,63.0,59.0,68.0,59-68,,,,,,9659748
123.0,null,patients,S. sordida,123.0,0.0,,,,,null,yes,,,,,5764372
12.0,Sham,patients,Group Constant,0.0,12.0,,,,,,,,,,,3506972
9.0,HPC,patients,Group Constant,0.0,9.0,,,,,,,,,,,3506972
8.0,Sham,patients,Group Inconstant,0.0,8.0,,,,,,,,,,,3506972
10.0,HPC,patients,Group Inconstant,0.0,10.0,,,,,,,,,,,3506972
5.0,Brucella pinnipedialis 12890,patients,B. pinnipedialis,0.0,5.0,,8.0,8.0,8.0,8 weeks,yes,,,,,4784796
5.0,Brucella ceti 12891,patients,B. ceti,0.0,5.0,,8.0,8.0,8.0,8 weeks,yes,,,,,4784796
5.0,Brucella suis 1330,patients,B. suis,0.0,5.0,,8.0,8.0,8.0,8 weeks,yes,,,,,4784796
6.0,null,patients,Group 1,3.0,3.0,,3.0,2.0,4.0,2-4,yes,,,,,3849430
78.0,none,patients,drug condition,10.0,68.0,20.24,,18.0,24.0,18-24,yes,,,,,6397859
164.0,none,patients,drug condition,24.0,140.0,20.27,,17.0,27.0,17-27,yes,,,,,6397859
5.0,healthy,healthy,volunteers,2.0,3.0,26.0,26.0,23.0,30.0,23-30,,,,,,5869699
10.0,healthy,healthy,volunteers,5.0,5.0,25.0,25.0,24.0,26.0,24-26,,,,,,5869699
6.0,arrhythmia,patients,patients,4.0,2.0,52.0,52.0,19.0,73.0,19-73,,,,,,5869699
6.0,SERT KO,patients,SERT KO mice,3.0,3.0,24.0,24.0,24.0,24.0,24-24,yes,,,,,8527018
8.0,elite athletes with a disability,patients,Paralympic swimmers,,,,,,,,yes,,,,,4456151
96.0,none,patients,C3H,48.0,48.0,,10.0,8.0,12.0,8-12,yes,,,,,7213687
96.0,none,patients,C57Bl/6,48.0,48.0,,10.0,8.0,12.0,8-12,yes,,,,,7213687
10.0,IL-1 knockout,patients,young,10.0,0.0,3.0,3.0,3.0,3.0,3-3,yes,,,,,5662897
8.0,IL-1 knockout,patients,adult,8.0,0.0,6.0,6.0,6.0,6.0,6-6,yes,,,,,5662897
11.0,IL-1r1 knockout,patients,young,11.0,0.0,3.0,3.0,3.0,3.0,3-3,yes,,,,,5662897
10.0,IL-1r1 knockout,patients,adult,10.0,0.0,6.0,6.0,6.0,6.0,6-6,yes,,,,,5662897
26.0,wild-type,healthy,young,26.0,0.0,3.0,3.0,3.0,3.0,3-3,yes,,,,,5662897
19.0,wild-type,healthy,adult,19.0,0.0,6.0,6.0,6.0,6.0,6-6,yes,,,,,5662897
62.0,first-episode schizophrenia,patients,first-episode,,,,,,,,yes,,,,,9819113
161.0,chronic schizophrenia,patients,chronic,,,,,,,,yes,,,,,9819113
151.0,control,healthy,controls,,,,,,,,yes,,,,,9819113
49.0,HIV control,patients,HIV control,49.0,0.0,35.53,,,,null,yes,,,,,10984160
16.0,HIV-associated anxiety disorders,patients,HIV ANXs,16.0,0.0,40.13,,,,null,yes,,,,,10984160
0.0,null,patients,Nf1,0.0,0.0,,,,,null,,,,,,6301684
0.0,null,healthy,Nf1 control,0.0,0.0,,,,,null,,,,,,6301684
639.0,null,patients,Katutura Community,,,,,18.0,80.0,18-80,no,,,,,4370519
134.0,cognitively unimpaired,patients,meditation,,,,,65.0,84.0,65-84,yes,,,,,10691714
50.0,none,healthy,Chinese college students,26.0,27.0,20.46,20.0,18.0,25.0,18-25,,,,,,10203786
33.0,Semantic Variant PPA,patients,SPPA,17.0,16.0,62.48,,53.0,87.0,53-87,yes,,,,,5619554
11.0,Nonfluent Progressive Aphasia,patients,NFPPA,3.0,8.0,66.45,,58.0,77.0,58-77,yes,,,,,5619554
3.0,Logopenic Progressive Aphasia,patients,LPPA,,,68.0,,,,,yes,,,,,5619554
21.0,Primary Progressive Aphasia,patients,PPA,,,60.88,,55.0,68.0,55-68,no,,,,,5619554
20.0,null,patients,tSMS20,,,,,,,null,yes,,,,,10104491
15.0,glioblastoma multiforme,patients,radiation oncologists,,,,,,,,yes,,,,,4489390
12.0,null,patients,VIP neurons,,,,,,,null,yes,,,,,4635925
13.0,left neglect,patients,right-hemisphere stroke patients,7.0,6.0,57.07,,,,N/A,yes,,,,,2600424
13.0,healthy controls,healthy,age-matched healthy participants,5.0,8.0,53.0,,,,N/A,yes,,,,,2600424
3309.0,end-stage renal disease (ESRD),patients,dialysis,,,61.7,,19.0,,19-,no,,,,,5832435
537.0,psychotic disorder,patients,AP polypharmacy,,,33.8,,18.0,65.0,18-65,yes,,,,,7652328
20.0,healthy,healthy,adults,11.0,9.0,28.4,28.0,25.0,32.0,25-32,,,,,,7500443
143.0,chronic kidney disease (CKD),patients,CKD,,,46.0,,18.0,75.0,18-75,yes,,,,,5598960
83.0,essential hypertension (HTN),healthy,HTN,,,53.0,,18.0,75.0,18-75,yes,,,,,5598960
795.0,obese,patients,obese men,795.0,0.0,,,,,unknown,yes,,,,,2639637
920.0,randomly sampled,healthy,randomly sampled men,920.0,0.0,,,,,unknown,yes,,,,,2639637
21.0,post-stroke aphasia,patients,chronic post-stroke aphasia,14.0,7.0,64.0,64.0,43.0,81.0,,yes,,,,,3187541
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,6392317
5.0,wt,patients,male,5.0,0.0,,,,,,,,,,,6179189
5.0,bab,patients,male,5.0,0.0,,,,,,,,,,,6179189
5.0,wt,healthy,male,5.0,0.0,,,,,,,,,,,6179189
5.0,low,healthy,male,5.0,0.0,,,,,,,,,,,6179189
5.0,high,healthy,male,5.0,0.0,,,,,,,,,,,6179189
25.0,none,healthy,Experiment 1,25.0,0.0,,,,,null,yes,,,,,4600472
46.0,none,healthy,Experiment 2,46.0,0.0,,,,,null,yes,,,,,4600472
10.0,none,healthy,Experiment 4,10.0,0.0,,,,,null,yes,,,,,4600472
13.0,none,healthy,Experiment 5,13.0,0.0,,,,,null,yes,,,,,4600472
39.0,healthy,healthy,Intentional,24.0,15.0,27.0,27.0,22.0,32.0,22-32,,,,,,4077469
40.0,healthy,healthy,Unintentional,24.0,16.0,28.0,28.0,21.0,35.0,21-35,,,,,,4077469
120.0,null,patients,PGS-E participants,0.0,120.0,,16.0,16.0,16.0,16-16,yes,,,,,3960334
262.0,Anorexia Nervosa,patients,AN cases,0.0,262.0,19.0,19.0,19.0,19.0,19-19,yes,,,,,3852189
80.0,No history of AN,healthy,controls,0.0,80.0,,,,,,yes,,,,,3852189
8.0,obesity,patients,Zucker-Lepr,8.0,0.0,,,,,,yes,,,,,4031175
8.0,healthy,healthy,Zucker-lean,8.0,0.0,,,,,,yes,,,,,4031175
0.0,null,patients,U937,,,,,,,null,,,,,,3720895
0.0,null,healthy,U937,,,,,,,null,,,,,,3720895
5.0,none,patients,2009 group,5.0,0.0,8.0,8.0,8.0,9.0,8-9,no,,,,,3559779
8.0,none,patients,2010 group,8.0,0.0,8.0,8.0,8.0,9.0,8-9,no,,,,,3559779
6.0,null,patients,class 1,1.0,0.0,,,,,,,,,,,8824366
6.0,null,patients,class 2,3.0,0.0,,,,,,,,,,,8824366
6.0,null,patients,class 3,1.0,0.0,,,,,,,,,,,8824366
500.0,null,patients,cultured sea urchins,,,,,,,null,,,,,,7161986
20.0,null,patients,wild sea urchins from barren,,,,,,,null,,,,,,7161986
20.0,null,patients,wild sea urchins from E. bicyclis bed,,,,,,,null,,,,,,7161986
97.0,TB,patients,confirmed TB cases,,,,,,,,yes,,,,,5234774
28.0,non-infectious conditions,healthy,hospitalized controls,,,,,,,,yes,,,,,5234774
120.0,null,patients,N2,,,,,,,null,yes,,,,,8248617
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,4460180
61.0,22q11.2 deletion syndrome,patients,22q11DS,25.0,36.0,15.68,,,,null,yes,,,,,2974935
27.0,major cardiac defects,patients,CHD,10.0,17.0,13.7,,,,null,yes,,,,,2974935
26.0,normal heart or benign murmurs,patients,noCHD,13.0,13.0,17.6,,,,null,yes,,,,,2974935
80.0,typically developing individuals,healthy,control,36.0,44.0,15.98,,,,null,yes,,,,,2974935
50.0,null,healthy,null,0.0,50.0,,,6.0,24.0,6 months - 2 years,yes,,,,,3438195
339.0,ASD,patients,ASD,,,,,,,,yes,,,,,8439051
0.0,,healthy,MRI,,,,,,,,,,,,,5065146
15.0,tolerant,patients,TOL,,,,,,,,yes,,,,,4361657
17.0,non-tolerant,patients,non-TOL,,,,,,,,yes,,,,,4361657
10.0,healthy control,healthy,control,3.0,7.0,32.5,32.5,27.0,59.0,27-59,no,,,,,4361657
156.0,null,patients,control,38.0,37.0,,,,,,,,,,,3838396
156.0,null,patients,nutritional restriction,41.0,38.0,,,,,,,,,,,3838396
368.0,melanoma survivors,patients,intervention,,,56.0,,24.0,75.0,24-75,yes,,,,,9916644
368.0,melanoma survivors,patients,control,,,56.0,,24.0,75.0,24-75,yes,,,,,9916644
4779.0,free from CVD,patients,MESA,,,61.9,,45.0,84.0,45-84,yes,,,,,8713797
24.0,null,patients,Female Sex Workers,0.0,24.0,23.5,23.0,18.0,32.0,18-32,no,,,,,3466319
3.0,neovascular AMD,patients,donors 1 to 3,,,,,,,,,,,,,6883845
4.0,no documented ophthalmic history,healthy,donors 5 to 7,,,,,,,,,,,,,6883845
8.0,null,healthy,SCAR-RNAi-expressing flies,,,,,,,,,,,,,6800343
8.0,null,healthy,WASp-RNAi-expressing flies,,,,,,,,,,,,,6800343
8.0,null,healthy,Rac1-CA-expressing flies,,,,,,,,,,,,,6800343
8.0,null,healthy,Cdc42-CA-expressing flies,,,,,,,,,,,,,6800343
8.0,null,healthy,Dia-RNAi-expressing flies,,,,,,,,,,,,,6800343
8.0,null,healthy,Parental controls,,,,,,,,,,,,,6800343
8.0,null,healthy,CK666-fed flies,,,,,,,,,,,,,6800343
8.0,null,healthy,Control flies,,,,,,,,,,,,,6800343
49.0,HCC,patients,HCC patients,,,51.0,,,,null,yes,,,,,4911053
1054.0,null,healthy,null,,,,,,,null,yes,,,,,3963945
13.0,none,patients,experimental group,6.0,7.0,23.6,23.0,22.0,25.0,22-25,,,,,,5507288
9.0,none,patients,control group,3.0,6.0,22.8,22.0,20.0,25.0,20-25,,,,,,5507288
19.0,aSAH,patients,IA therapy,,,,,,,,yes,,,,,5365119
153.0,ischemic stroke,patients,overall,,,65.4,,28.0,94.0,28-94,yes,,,,,3922971
64.0,null,patients,male,64.0,0.0,19.5,,,,null,yes,,,,,4242515
92.0,null,patients,female,0.0,92.0,19.5,,,,null,yes,,,,,4242515
106.0,cancer pain,patients,naldemedine,,,,,,,,yes,,,,,9733844
300.0,advanced cancer,patients,CGP testing,,,,,,,,yes,,,,,10218744
120.0,Chronic Fatigue Syndrome,patients,CFS,34.0,86.0,,,,,,yes,,,,,4608737
18444.0,2009 H1N1 vaccination,patients,RCTs,,,,,,,,,,,,,3167852
897.0,healthy,healthy,self-reported healthy individuals,556.0,341.0,39.7,39.0,20.0,70.0,20-70,no,,,,,5414997
58.0,anxiety,patients,petting animals,,,,,,,,yes,,,,,5482437
6.0,vegetative or minimally conscious state,patients,fMRI study participants,3.0,3.0,,,,,,,,,,,7116773
18.0,submucosal myoma (SMM),patients,SMM,0.0,18.0,40.8,,,,null,yes,,,,,7665806
16.0,intramural myoma (IMM),patients,IMM,0.0,16.0,,,,,null,yes,,,,,7665806
17.0,subserosal myoma (SSM),patients,SSM,0.0,17.0,36.3,,,,null,yes,,,,,7665806
400.0,healthy,healthy,young adults,200.0,200.0,40.9,40.0,25.0,45.0,,,,,,,3866135
212.0,ICUAW,patients,ICU patients,,,,,,,,yes,,,,,4210178
23.0,healthy,healthy,HMP,,,,,,,,,,,,,7892788
17.0,healthy,healthy,LMP,,,,,,,,,,,,,7892788
8.0,none,patients,C57Bl/6 male mice,8.0,0.0,,9.0,8.0,10.0,8-10,no,,,,,2888573
316.0,null,patients,younger,,,,,20.0,40.0,20-40,yes,,,,,6224233
316.0,null,patients,older,,,,,60.0,90.0,60-90,yes,,,,,6224233
5518.0,healthy,healthy,women,0.0,5518.0,70.2,,65.0,82.0,65-82,yes,,,,,10654785
7595.0,healthy,healthy,men,7595.0,0.0,70.84,,65.0,82.0,65-82,yes,,,,,10654785
8.0,Control,patients,Control,8.0,0.0,,,,,,,,,,,3871554
8.0,TSP-2 treated,patients,TSP-2 treated,8.0,0.0,,,,,,,,,,,3871554
25.0,sudden sensorineural hearing loss (SNHL),patients,sudden SNHL,14.0,11.0,,,,,,,,,,,5600057
8.0,healthy,healthy,healthy volunteers,8.0,0.0,,,,,,,,,,,5600057
15.0,SOD1 mice,patients,Ubiquinone treatment,0.0,15.0,,,,,,yes,,,,,3720666
15.0,SOD1 mice,patients,Ubiquinol treatment,0.0,15.0,,,,,,yes,,,,,3720666
119.0,none,patients,overall,58.0,61.0,21.0,21.0,18.0,24.0,18-24,,,,,,9739676
1.0,schizophrenia,patients,Case 1,1.0,0.0,45.0,45.0,45.0,45.0,,,,,,,8374077
1.0,schizophrenia,patients,Case 2,0.0,1.0,46.0,46.0,46.0,46.0,,,,,,,8374077
100.0,,healthy,late adolescents,18.0,82.0,19.8,19.0,18.0,22.0,18-22,,,,,,4951620
4.0,null,patients,Control,,,,,,,null,no,,,,,3772078
4.0,null,patients,Gravity (G),,,,,,,null,no,,,,,3772078
4.0,null,patients,Gravity + LIPUS (GU),,,,,,,null,no,,,,,3772078
4.0,null,patients,SMG (M),,,,,,,null,no,,,,,3772078
4.0,null,patients,SMG + LIPUS (MU),,,,,,,null,no,,,,,3772078
211.0,null,patients,whole blood,,,75.0,,22.0,96.0,22-96,yes,,,,,3465258
20.0,null,patients,MNCs and PMNCs,10.0,10.0,45.0,,22.0,96.0,22-96,yes,,,,,3465258
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,3616012
14.0,"49,XXXXY",patients,"49,XXXXY males",14.0,0.0,,,5.0,17.0,5.1-17.2,yes,,,,,3649771
7.0,POTS,patients,adolescents,3.0,4.0,,,15.0,18.0,,yes,,,,,4751215
0.0,null,patients,null,0.0,0.0,,,,,null,,,,,,3753296
0.0,null,healthy,null,0.0,0.0,,,,,null,,,,,,3753296
370.0,"HIV, OLD",patients,HIV-infected with OLD,,,,,,,,yes,,,,,3990590
280.0,none,healthy,disease-free participants,,,,,,,,yes,,,,,3990590
1.0,infectious mononucleosis,patients,acute infectious mononucleosis,1.0,0.0,19.0,19.0,19.0,19.0,19-19,yes,,,,,3073885
0.0,,healthy,S. epidermidis CH,,,,,,,,no,,,,,1762332
208.0,null,healthy,midwives,2.0,206.0,34.0,34.0,28.0,43.0,28-43.5,no,,,,,6483190
20.0,healthy,healthy,community dwelling participants,10.0,10.0,61.15,,55.0,73.0,55-73,yes,,,,,8548419
10.0,null,patients,small,,,,,,,null,,,,,,4357454
10.0,null,patients,medium,,,,,,,null,,,,,,4357454
10.0,null,patients,large,,,,,,,null,,,,,,4357454
1.0,null,patients,1-month-old human cadaver,1.0,0.0,1.0,1.0,1.0,1.0,1-1,yes,,,,,4500468
1.0,null,patients,3-week-old piglet,1.0,0.0,3.0,3.0,3.0,3.0,3-3,yes,,,,,4500468
330.0,MSA,patients,MSA,,,,,,,,,,,,,3152869
297.0,PSP,patients,PSP,,,,,,,,,,,,,3152869
7.0,healthy,healthy,pigs,,,,,,,,yes,,,,,5617181
21.0,healthy,healthy,experiment 1,6.0,15.0,24.5,24.0,21.0,30.0,21-30,,,,,,6054979
30.0,healthy,healthy,experiment 2,7.0,23.0,21.0,21.0,18.0,27.0,18-27,,,,,,6054979
42.0,malaria transmission perceptions,patients,participants,12.0,30.0,38.9,,19.0,72.0,19-72,no,,,,,6546273
35.0,ischemic or hemorrhagic stroke,patients,stroke survivors with visual impairment,19.0,16.0,,,20.0,75.0,,yes,,,,,5607544
113.0,HIV/HBV co-infected,patients,HIV/HBV co-infected patients,50.0,63.0,45.0,45.0,24.0,73.0,24-73,yes,,,,,7790253
6.0,Alzheimers disease,patients,APP TgCRND8,3.0,3.0,6.0,6.0,3.0,9.0,,yes,,,,,9327202
213.0,IHD,patients,active group,,,,,,,,,,,,,4029626
107.0,IHD,patients,TAU,,,,,,,,,,,,,4029626
18.0,OPLL,patients,OPLL patients,,,,,,,,,,,,,4156358
18.0,non-OPLL,patients,non-OPLL patients,,,,,,,,,,,,,4156358
1463.0,MS,patients,MS patients,,,28.3,,15.0,45.0,15-45,yes,,,,,7984655
798.0,null,patients,QTIM,311.0,487.0,22.0,22.0,12.0,30.0,12-30,,,,,,11128777
396.0,null,patients,QTAB,195.0,201.0,11.0,11.0,9.0,16.0,9-16,,,,,,11128777
23.0,WP users,patients,current WP users,,,,,,,,yes,,,,,10038263
40.0,nonusers,healthy,nonusers,,,,,,,,yes,,,,,10038263
29.0,none,patients,cynomolgus monkeys,29.0,0.0,24.0,24.0,24.0,24.0,24-24,yes,,,,,9202903
30.0,"typically developing (TD) children, children with attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD)",patients,TD,5.0,8.0,10.42,10.0,9.0,11.0,9-11,,,,,,4347448
6.0,autism spectrum disorder (ASD),patients,ASD,6.0,0.0,9.74,10.0,9.0,10.0,9-10,,,,,,4347448
11.0,attention deficit hyperactivity disorder (ADHD),patients,ADHD,4.0,7.0,10.2,10.0,9.0,11.0,9-11,,,,,,4347448
16.0,"normal aging, mild cognitive impairment (MCI), Alzheimer's disease (AD), impairment but not MCI",patients,elderly,4.0,3.0,60.09,60.0,58.0,63.0,58-63,,,,,,4347448
2.0,mild cognitive impairment (MCI),patients,MCI,1.0,1.0,63.6,63.0,63.0,64.0,63-64,,,,,,4347448
5.0,Alzheimer's disease (AD),patients,AD,3.0,2.0,68.64,69.0,68.0,69.0,68-69,,,,,,4347448
2.0,impaired but not MCI,patients,impaired,1.0,1.0,58.65,59.0,58.0,59.0,58-59,,,,,,4347448
10.0,essential tremor,patients,human ET patients,4.0,6.0,,,60.0,79.0,,yes,,,,,10805384
9.0,none,patients,Long-Evans rats,9.0,0.0,,,,,,yes,,,,,10805384
7.0,genetic absence epilepsy,patients,GAERS rats,,,,,,,,yes,,,,,10805384
5.0,none,patients,C57BL/6 mice,5.0,0.0,,,9.0,16.0,,yes,,,,,10805384
0.0,null,patients,n3,,,,,,,,,,,,,3695931
0.0,null,patients,PPm3,,,,,,,,,,,,,3695931
12.0,healthy,healthy,C57/Bl6,12.0,0.0,,,,,,,,,,,3248414
6.0,healthy,healthy,Kv4.2/,6.0,0.0,,,,,,,,,,,3248414
7.0,ischemic,patients,ischemic,7.0,0.0,,,,,,,,,,,3309937
7.0,normal,healthy,normal,7.0,0.0,,,,,,,,,,,3309937
1484.0,null,patients,White,,,,,5.0,11.0,5-11,yes,,,,,4412635
1484.0,null,patients,Black,,,,,5.0,11.0,5-11,yes,,,,,4412635
1484.0,null,patients,South Asian,,,,,5.0,11.0,5-11,yes,,,,,4412635
1484.0,null,patients,Other,,,,,5.0,11.0,5-11,yes,,,,,4412635
2.0,ALS,patients,FUS-R518G,1.0,1.0,60.0,60.0,30.0,90.0,30-90,yes,,,,,3631215
0.0,null,patients,HeLa,,,,,,,,,,,,,4154836
0.0,null,patients,SiHa,,,,,,,,,,,,,4154836
0.0,,healthy,C57Bl/6J mice,,,,,,,,,,,,,3469557
0.0,,healthy,Trpa1 mice,,,,,,,,,,,,,3469557
0.0,,healthy,Trpv1 mice,,,,,,,,,,,,,3469557
0.0,,healthy,wild-type littermates,,,,,,,,,,,,,3469557
233.0,lung transplantation,patients,overall,148.0,85.0,52.97,,,,N/A,yes,,,,,5509107
8.0,clinically normal,healthy,koalas,4.0,4.0,4.9,4.0,2.0,7.0,2.8-7.5,no,,,,,11023281
1.0,choroid plexus carcinoma,patients,CPC patients,1.0,0.0,73.0,73.0,73.0,73.0,73-73,yes,,,,,4489946
40.0,"T2D, obesity, hyperglycemia, insulin-resistance and hyperinsulinemia",patients,db/db mice,40.0,0.0,,,,,,,,,,,3174932
388017.0,Laysan albatross,healthy,Laysan albatross,,,,,,,,yes,,,,,4580421
25433.0,black-footed albatross,healthy,black-footed albatross,,,,,,,,yes,,,,,4580421
129733.0,Bonin petrel,healthy,Bonin petrel,,,,,,,,yes,,,,,4580421
169.0,acute coronary syndrome,patients,current smokers,,,55.7,,,,unknown,yes,,,,,4619630
307.0,stable coronary artery disease,patients,never smokers,,,64.4,,,,unknown,yes,,,,,4619630
17.0,early AD,patients,AD patients,,,,,,,,yes,,,,,6700635
35.0,neurological controls,healthy,controls,10.0,25.0,57.3,,45.0,70.0,45-70,yes,,,,,6700635
19.0,null,patients,null,,,25.4,,,,null,,,,,,7351776
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,4807836
30.0,none,patients,Heading,15.0,15.0,23.53,23.0,18.0,30.0,18-30,,,,,,10157247
30.0,none,patients,VR,15.0,15.0,25.73,25.0,18.0,30.0,18-30,,,,,,10157247
824.0,nephrolithiasis,patients,dietary intervention,,,,,,,,yes,,,,,8055022
15.0,none,healthy,young adults,7.0,8.0,22.0,22.0,18.0,25.0,18-25,,,,,,4357296
15.0,none,healthy,older adults,5.0,10.0,75.0,75.0,63.0,92.0,63-92,,,,,,4357296
1.0,healthy,healthy,male volunteer,1.0,0.0,,,,,,yes,,,,,6560237
31791.0,obesity,patients,bariatric surgery cohort,,,42.0,,30.0,55.0,30-55,yes,,,,,10194874
263.0,MS,patients,MS patients,,,,,,,,yes,,,,,10509529
207.0,NMOSD,patients,NMOSD patients,,,,,,,,yes,,,,,10509529
338.0,HC,healthy,healthy controls,,,,,,,,yes,,,,,10509529
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,3261891
7010.0,HIV-positive,patients,adults,2445.0,4565.0,37.0,37.0,15.0,90.0,15-90,no,,,,,5515476
12.0,Parkinson's disease,patients,STN recordings,,,,,,,,,,,,,7096181
4.0,null,patients,Macaca fascicularis,2.0,2.0,,,,,null,yes,,,,,2777259
1.0,malignant melanoma,patients,A375 cell line,0.0,1.0,54.0,54.0,54.0,54.0,54-54,yes,,,,,4807832
0.0,null,patients,LNCaP,,,,,,,null,,,,,,3547877
0.0,null,patients,LNCaP-AI,,,,,,,null,,,,,,3547877
0.0,null,healthy,COS-7,,,,,,,null,,,,,,3547877
0.0,null,healthy,PC3,,,,,,,null,,,,,,3547877
1.0,insomnia,patients,insomnia patients,,,,,,,,yes,,,,,10343953
1.0,depression,patients,patients with melancholic major depressive disorder with insomnia,,,,,,,,yes,,,,,10343953
1.0,temporal lobe epilepsy,patients,TLE patients with sleep disorders,,,,,,,,yes,,,,,10343953
1.0,Alzheimer's disease,patients,Alzheimer's patients with sleep disorders,,,,,,,,yes,,,,,10343953
29.0,healthy,patients,Diabetes during pregnancy,14.0,15.0,,,,,,yes,,,,,7473588
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,9847973
0.0,null,healthy,null,0.0,0.0,,,,,,,,,,,9847973
5.0,"normal diet, no antibiotics nor essential oils added to the diet",healthy,white diet,,,,,,,,,,,,,8901073
6.0,antibiotics added to the diet,patients,traditional diet,,,,,,,,,,,,,8901073
6.0,essential oils added to the diet,patients,oil diet,,,,,,,,,,,,,8901073
64.0,null,patients,older,30.0,34.0,70.64,70.0,65.0,77.0,65-77,,,,,,6428309
39.0,null,patients,younger,17.0,22.0,28.74,22.0,18.0,55.0,18-55,,,,,,6428309
7.0,null,healthy,BHK21,,,,,,,,,,,,,2889835
7.0,null,healthy,BSRT7,,,,,,,,,,,,,2889835
7.0,null,healthy,HeLa,,,,,,,,,,,,,2889835
7.0,null,healthy,A549,,,,,,,,,,,,,2889835
7.0,null,healthy,4T1,,,,,,,,,,,,,2889835
7.0,null,healthy,HEp2,,,,,,,,,,,,,2889835
7.0,null,healthy,Vero,,,,,,,,,,,,,2889835
15.0,anemia,patients,mothers or caregivers,0.0,15.0,22.84,,18.0,33.0,,,,,,,10035874
0.0,,healthy,MRI,,,,,,,,,,,,,4689534
12114.0,COVID-19 seroprevalence study,patients,first round,,,,,,,,yes,,,,,9132278
72.0,null,patients,MRI participants,13.0,59.0,20.5,,18.0,26.0,18-26,yes,,,,,9828266
1.0,null,patients,C57/Bl6 mice,,,,,,,8-wk,yes,,,,,10469016
296.0,null,patients,2019,,,25.7,,19.0,50.0,19-50,yes,,,,,10586704
291.0,null,patients,2021,,,26.5,,19.0,50.0,19-50,yes,,,,,10586704
36.0,healthy,healthy,young males,36.0,0.0,25.4,,20.0,40.0,20-40,yes,,,,,3907676
49.0,MK,patients,Y2020,,,,,,,,,,,,,8372897
181.0,MK,patients,pre-C19,,,,,,,,,,,,,8372897
1284.0,various diseases including cancer,patients,development cohort,,,77.0,77.0,58.0,101.0,58-101,yes,,,,,4581840
98.0,metastatic cancer,patients,validation cohort,,,,,,,,yes,,,,,4581840
91.0,null,patients,Libyan dental practitioners,15.0,43.0,,,,,null,yes,,,,,10781111
68.0,autistic,patients,autistic children,,,,,6.0,11.0,6.0-11.0,yes,,,,,11130426
70.0,non-autistic,healthy,non-autistic children,,,,,6.0,11.0,6.0-11.0,yes,,,,,11130426
2395.0,post-ERCP pancreatitis,patients,GTN group,,,,,,,,,,,,,3787965
2395.0,post-ERCP pancreatitis,patients,placebo group,,,,,,,,,,,,,3787965
20.0,healthy,healthy,volunteers,,,,,,,,,,,,,2424135
45194.0,null,patients,colorectal cancer,14172.0,31022.0,,,,,null,,,,,,4643904
20.0,nave,patients,Group 1,10.0,10.0,,4.0,3.0,6.0,3-6,,,,,,3142111
20.0,immunized,patients,Group 2,10.0,10.0,,4.0,3.0,6.0,3-6,,,,,,3142111
21.0,PAC (Post-Abortion Care),patients,PAC Patients,0.0,21.0,,,,,,yes,,,,,6150499
17.0,heart failure,patients,HF participants,,,,,,,,yes,,,,,11125520
9.0,Iron deficiency anemia,patients,A,,,,,,,,yes,,,,,3667775
9.0,Iron deficiency anemia,patients,B,,,,,,,,yes,,,,,3667775
9.0,Iron deficiency anemia,patients,C,,,,,,,,yes,,,,,3667775
18.0,healthy,healthy,participants,8.0,10.0,22.0,22.0,20.0,25.0,20-25,,,,,,8260738
13.0,healthy,healthy,participants with N3 sleep,4.0,9.0,22.0,22.0,20.0,25.0,20-25,,,,,,8260738
156.0,healthy,healthy,active males,,,,,9.0,31.0,9.22-31,yes,,,,,9725163
3.0,Chronic Myelomonocytic Leukemia,patients,MV-4-11,,,,,,,,,,,,,3281857
3.0,Chronic Myelomonocytic Leukemia,patients,HL-60,,,,,,,,,,,,,3281857
3.0,Chronic Myelomonocytic Leukemia,patients,U-937,,,,,,,,,,,,,3281857
28.0,ASD,patients,ASD adults,,,,,,,,yes,,,,,6461820
27.0,TD,healthy,TD adults,,,,,,,,yes,,,,,6461820
355.0,null,patients,Southern Italy,159.0,192.0,45.79,45.0,27.0,72.0,,,,,,,7735630
1147.0,critically ill patients,patients,SOC group,,,,,,,,yes,,,,,3842947
1147.0,critically ill patients,patients,high-exposure group,,,,,,,,yes,,,,,3842947
20.0,healthy,healthy,volunteers,10.0,10.0,30.8,30.0,20.0,40.0,20-40,,,,,,3419733
3.0,healthy,healthy,saliva donors,3.0,0.0,29.3,29.0,20.0,40.0,20-40,,,,,,3419733
12.0,nicotine exposure,patients,F1 nicotine male,12.0,0.0,,,,,,,,,,,6191076
11.0,nicotine exposure,patients,F1 female nicotine,0.0,11.0,,,,,,,,,,,6191076
18.0,control,healthy,F1 water male,18.0,0.0,,,,,,,,,,,6191076
13.0,control,healthy,F1 water female,0.0,13.0,,,,,,,,,,,6191076
256.0,healthy,healthy,male,256.0,0.0,21.8,22.0,18.0,25.0,18-25,yes,,,,,8943682
40.0,HCC,patients,HCC patients,,,,,,,,,,,,,5991670
38.0,healthy,healthy,healthy individuals,,,,,,,,,,,,,5991670
1097.0,renal cell carcinoma,patients,cases,,,,,20.0,79.0,20-79,yes,,,,,3198392
1497.0,not related to smoking or genitourinary disorders,healthy,controls,,,,,,,,yes,,,,,3198392
194.0,RA,patients,Cluster A,,,,,,,,,,,,,6655687
256.0,RA,patients,Cluster B,,,,,,,,,,,,,6655687
188.0,Mixed RA and OA,patients,Cluster C,,,,,,,,,,,,,6655687
363.0,OA,patients,Cluster D,,,,,,,,,,,,,6655687
232.0,Mixed RA and OA,patients,Cluster E,,,,,,,,,,,,,6655687
12.0,Pituitary dwarfism,patients,untreated dwarfs,,,,,,,,yes,,,,,8351940
22.0,Pituitary dwarfism,patients,treated with levothyroxine,,,,,,,,yes,,,,,8351940
13.0,Pituitary dwarfism,patients,treated with levothyroxine and progestogens or GH,,,,,,,,yes,,,,,8351940
94.0,normal stature,healthy,control group,,,,,,,,yes,,,,,8351940
30.0,none,healthy,active,11.0,19.0,,,18.0,30.0,18-30,,,,,,8447044
0.0,null,patients,null,,,,,,,,,,,,,4687847
20.0,prepresbyopic,healthy,prepresbyopic volunteers,11.0,9.0,25.95,26.0,25.0,26.0,25-26,yes,,,,,4130593
0.0,,healthy,ASCs,,,,,,,,no,,,,,4806986
118.0,MDD,patients,MDD,36.0,82.0,,,18.0,56.0,18-56,yes,,,,,4449319
56.0,asthma,patients,high PAH exposure,,,,,,,,,,,,,2637989
56.0,nonasthmatic,patients,low PAH exposure,,,,,,,,,,,,,2637989
1258.0,breast cancer,patients,AA and White women,,,56.0,56.0,35.0,65.0,35-65,yes,,,,,6005569
12.0,Q fever endocarditis,patients,men,12.0,0.0,,,36.0,75.0,36-75,yes,,,,,4161472
5.0,Q fever endocarditis,patients,women,0.0,5.0,,,42.0,64.0,42-64,yes,,,,,4161472
11.0,healthy,healthy,men,6.0,5.0,,,26.0,65.0,26-65,yes,,,,,4161472
11.0,healthy,healthy,women,7.0,4.0,,,30.0,70.0,30-70,yes,,,,,4161472
9.0,acute Q fever,patients,men,6.0,3.0,,,42.0,71.0,42-71,yes,,,,,4161472
9.0,acute Q fever,patients,women,6.0,3.0,,,40.0,68.0,40-68,yes,,,,,4161472
33.0,non-AMD control,healthy,Cohort 1,,,,,,,,,,,,,7413518
24.0,AREDS 3,patients,Cohort 1,,,,,,,,,,,,,7413518
37.0,GA,patients,Cohort 1,,,,,,,,,,,,,7413518
29.0,non-AMD control,healthy,Cohort 2,,,,,,,,,,,,,7413518
22.0,AREDS 3,patients,Cohort 2,,,,,,,,,,,,,7413518
35.0,GA,patients,Cohort 2,,,,,,,,,,,,,7413518
18.0,cystic fibrosis,patients,itraconazole,,,,,,,,yes,,,,,3340414
17.0,cystic fibrosis,patients,placebo,,,,,,,,yes,,,,,3340414
1046.0,null,patients,CCLE dataset,,,,,,,null,yes,,,,,4103868
500.0,null,healthy,HCP 500,,,,,,,null,yes,,,,,6779267
24.0,null,patients,hypnotic suggestion,0.0,24.0,,,18.0,45.0,18-45,yes,,,,,6608544
24.0,null,patients,tDCS,0.0,24.0,,,18.0,45.0,18-45,yes,,,,,6608544
0.0,null,patients,null,0.0,0.0,,,,,null,,,,,,8221488
0.0,null,healthy,null,0.0,0.0,,,,,null,,,,,,8221488
80.0,null,patients,null,21.0,59.0,26.3,26.0,20.0,35.0,20-35,yes,,,,,9584910
8.0,Ang-II infusion,patients,SA,8.0,0.0,,,,,,,,,,,3498357
8.0,Ang-II infusion,patients,NT,8.0,0.0,,,,,,,,,,,3498357
0.0,null,patients,VS/UWS,,,,,,,null,,,,,,7522478
0.0,null,patients,MCS,,,,,,,null,,,,,,7522478
0.0,null,patients,MCS+,,,,,,,null,,,,,,7522478
0.0,null,patients,LIS,,,,,,,null,,,,,,7522478
0.0,null,healthy,null,,,,,,,null,,,,,,7522478
12.0,LTBI,patients,stable HBHA- and rESAT-6-IGRA profile,,,,,,,,yes,,,,,3422279
7.0,LTBI,patients,changing HBHA- and rESAT-6-IGRA profile,,,,,,,,yes,,,,,3422279
4.0,LTBI,patients,disappearing HBHA- and rESAT-6-IGRA responses,,,,,,,,yes,,,,,3422279
0.0,,healthy,Miconia albicans,,,,,,,,,,,,,6197632
0.0,,healthy,Miconia ibaguensis,,,,,,,,,,,,,6197632
0.0,,healthy,Ditylenchus gallaeformans,,,,,,,,,,,,,6197632
0.0,,healthy,Eriophyidae,,,,,,,,,,,,,6197632
910.0,hip fracture,patients,UI,,,82.7,,65.0,100.0,65-100,yes,,,,,9151507
910.0,hip fracture,patients,DI,,,82.7,,65.0,100.0,65-100,yes,,,,,9151507
41.0,pulmonary hypertension,patients,PH patients,13.0,28.0,,,,,,,,,,,5501558
12.0,idiopathic or heritable pulmonary arterial hypertension (PAH),patients,PAH patients,,,41.2,,,,,,,,,,5501558
29.0,chronic thromboembolic pulmonary hypertension (CTEPH),patients,CTEPH patients,,,63.7,,,,,,,,,,5501558
1116.0,N/A,patients,young women,0.0,1116.0,,,16.0,25.0,16-25,no,,,,,3360595
40.0,ICU survivors,patients,InS:PIRE cohort,25.0,15.0,,,,,,,,,,,5706708
52.0,historical control,patients,historical control group,31.0,21.0,,,,,,,,,,,5706708
5122.0,migraine,patients,any migraine,,,,,,,,yes,,,,,3136515
33.0,behavioural-variant frontotemporal dementia,patients,high emotional apathy,,,,,,,,,,,,,10049956
14.0,Alzheimers disease,patients,high emotional apathy,,,,,,,,,,,,,10049956
8.0,semantic dementia,patients,high emotional apathy,,,,,,,,,,,,,10049956
6.0,progressive nonfluent aphasia,patients,high emotional apathy,,,,,,,,,,,,,10049956
3.0,logopenic progressive aphasia,patients,high emotional apathy,,,,,,,,,,,,,10049956
12.0,behavioural-variant frontotemporal dementia,patients,low emotional apathy,,,,,,,,,,,,,10049956
12.0,Alzheimers disease,patients,low emotional apathy,,,,,,,,,,,,,10049956
5.0,semantic dementia,patients,low emotional apathy,,,,,,,,,,,,,10049956
5.0,progressive nonfluent aphasia,patients,low emotional apathy,,,,,,,,,,,,,10049956
2.0,logopenic progressive aphasia,patients,low emotional apathy,,,,,,,,,,,,,10049956
27.0,healthy controls,healthy,controls,,,,,,,,,,,,,10049956
20.0,lead exposure,patients,male Wistar rats,20.0,0.0,,,,,null,yes,,,,,8413791
30.0,diabetes-free survival,patients,C3/ mice,,,,,,,,yes,,,,,3688892
25.0,hyperglycemia,patients,C3+/+ mice,,,,,,,,yes,,,,,3688892
0.0,null,patients,null,0.0,0.0,,,,,null,no,,,,,7063673
30.0,null,patients,DR,10.0,20.0,,,,,null,,,,,,4726667
15.0,null,patients,NR,,,,,,,null,,,,,,4726667
36.0,healthy,healthy,experiment one,17.0,19.0,26.0,26.0,20.0,40.0,20-40,yes,,,,,4958375
32.0,healthy,healthy,experiment two,14.0,18.0,27.0,27.0,20.0,40.0,20-40,yes,,,,,4958375
252.0,OPSCC,patients,p16 positive,221.0,31.0,60.5,60.0,26.0,98.0,26-98,,,,,,8211260
252.0,OPSCC,patients,p16 negative,,,,,,,,,,,,,8211260
0.0,,healthy,null,,,,,,,,,,,,,6013242
0.0,,healthy,null,,,,,,,,,,,,,6013242
27.0,remitted MDD,patients,remitted MDD,5.0,22.0,25.6,25.0,18.0,40.0,18-40,,,,,,3783899
29.0,healthy,healthy,control,7.0,22.0,22.7,22.0,18.0,30.0,18-30,,,,,,3783899
72.0,null,patients,Experiment 1,,,,,,,null,,,,,,5929902
72.0,null,patients,Experiment 2,,,,,,,null,,,,,,5929902
72.0,null,patients,Experiment 3,,,,,,,null,,,,,,5929902
15.0,enteritis,patients,MTX group,,,,,,,,,,,,,2945766
15.0,enteritis,patients,MTX+curcumin group,,,,,,,,,,,,,2945766
15.0,enteritis,patients,MTX+NAC group,,,,,,,,,,,,,2945766
15.0,enteritis,patients,control group,,,,,,,,,,,,,2945766
14.0,sub-cortical ischemic stroke,patients,stroke patients,10.0,4.0,66.9,,55.0,78.0,55-78,yes,,,,,6056631
80.0,HIV negative,patients,MSM,,,24.9,24.0,18.0,29.0,18-29,,,,,,4830617
14.0,operculo-insular epilepsy (OIE),patients,OIE,5.0,9.0,33.7,,19.0,46.0,19-46,,,,,,6040575
9.0,medically intractable temporal lobe epilepsy (TLE),patients,TLE,4.0,5.0,27.6,,18.0,36.0,18-36,,,,,,6040575
26.0,healthy individuals,healthy,HC,13.0,13.0,28.5,,23.0,40.0,23-40,,,,,,6040575
4835.0,frequent ED users,patients,frequent ED users,,,,,,,,,,,,,4726528
286.0,Type 2 Diabetes Mellitus,patients,Diabetic Patients,73.0,213.0,51.0,51.0,18.0,90.0,18-90,yes,,,,,9447889
150.0,PD,patients,PD-CN,,,,,,,,,,,,,8874137
150.0,PD,patients,PD-MCI,,,,,,,,,,,,,8874137
150.0,PD,patients,PDD,,,,,,,,,,,,,8874137
0.0,,healthy,hAECs,,,,,,,,no,,,,,5870984
4.0,Cry-resistant,patients,H. virescens,,,,,,,,,,,,,3046977
2.0,Cry-resistant,patients,H. armigera,,,,,,,,,,,,,3046977
2.0,Cry-resistant,patients,S. frugiperda,,,,,,,,,,,,,3046977
15.0,VML only (negative control),patients,VML only,15.0,0.0,,,,,,,,,,,7505427
15.0,VML+SMU,patients,VML+SMU,15.0,0.0,,,,,,,,,,,7505427
768.0,,healthy,sexual abuse history,331.0,421.0,61.2,,,,59.9-62.8,yes,,,,,3893132
12643.0,type 2 diabetes,patients,overall,,,57.2,,18.0,100.0,18-100,no,,,,,4210124
11.0,NFL-KO,patients,5 months,,,,,,,,yes,,,,,6808381
7.0,WT,healthy,5 months,,,,,,,,yes,,,,,6808381
6.0,NFL-KO,patients,22 months,,,,,,,,yes,,,,,6808381
7.0,WT,healthy,22 months,,,,,,,,yes,,,,,6808381
22.0,Cystic Fibrosis,patients,G542X mutation,11.0,11.0,,,,,,yes,,,,,6010256
10.0,Cystic Fibrosis,patients,CF Patients,,,,,,,,yes,,,,,9122229
7073.0,HIV or AIDS,patients,single pill per day,,,45.0,,,,null,no,,,,,3286454
7073.0,HIV or AIDS,patients,two pills per day,,,45.0,,,,null,no,,,,,3286454
7073.0,HIV or AIDS,patients,three or more pills per day,,,45.0,,,,null,no,,,,,3286454
620.0,MCI,patients,overall,,,,,,,,yes,,,,,8249246
1433.0,gonorrhoea,patients,MSM,1310.0,123.0,31.0,31.0,16.0,86.0,16-86,no,,,,,5730201
1433.0,gonorrhoea,patients,MSW,506.0,927.0,31.0,31.0,16.0,86.0,16-86,no,,,,,5730201
1433.0,gonorrhoea,patients,women,1388.0,45.0,,,,,,no,,,,,5730201
80.0,AD,patients,AD patients,,,,,,,,yes,,,,,3616972
79.0,healthy controls,healthy,healthy controls,,,,,,,,yes,,,,,3616972
243.0,typically developing,patients,children and adolescents,120.0,123.0,11.73,,9.0,15.0,9-15,yes,,,,,9374891
113605.0,null,patients,HEXA-G,,,,,,,null,yes,,,,,5906014
164.0,healthy,healthy,full-term newborns with family history of CD,,,,,,,,yes,,,,,3272021
350.0,null,patients,C. stygia,,,,,,,null,yes,,,,,3760806
140.0,none,healthy,Cuviers gazelle,53.0,95.0,,,,,,,,,,,4682998
26.0,healthy,healthy,experiment 1,2.0,12.0,24.6,24.0,24.0,25.0,24-25,,,,,,4510640
12.0,healthy,healthy,experiment 2,4.0,8.0,24.5,24.0,24.0,25.0,24-25,,,,,,4510640
141.0,null,patients,fat suppressed contrast-enhanced T1-weighted MRI,64.0,77.0,58.0,58.0,18.0,94.0,18-94,,,,,,8960587
84.0,null,patients,T1-weighted MRI,40.0,44.0,56.0,56.0,18.0,87.0,18-87,,,,,,8960587
71.0,null,patients,both scan sequences,34.0,37.0,58.0,58.0,17.0,87.0,17-87,,,,,,8960587
63.0,stage 3 CKD and hyperuricemia,patients,allopurinol,,,,,,,,,,,,,6200237
63.0,stage 3 CKD and hyperuricemia,patients,placebo,,,,,,,,,,,,,6200237
20.0,healthy,healthy,young adults,,,,,,,,,,,,,3873305
9.0,healthy,healthy,young adults,,,,,,,,,,,,,3873305
1301.0,HIV,patients,MSM,,,22.5,22.0,12.0,71.0,12-71,no,,,,,3212560
12.0,null,patients,Sprague Dawley rats,6.0,6.0,,,8.0,12.0,8-12,yes,,,,,3813445
5083.0,null,patients,19 years and under,,,,,,,null,yes,,,,,6292636
5083.0,null,patients,20-34 years,,,,,,,null,yes,,,,,6292636
5083.0,null,patients,35 years and over,,,,,,,null,yes,,,,,6292636
25.0,healthy,healthy,women,0.0,25.0,45.0,45.0,40.0,50.0,40-50,no,,,,,3946127
1164.0,NCD risk factors,patients,Haramaya University employees,,,31.9,,30.0,69.0,30-69,yes,,,,,8884490
436.0,breast cancer,patients,AIs-related MS-AEs Group,0.0,436.0,,,,,,yes,,,,,3716812
402.0,Special educational needs and disabilities (SEND),patients,SEND,258.0,144.0,13.04,13.0,1.0,45.0,1-45,no,,,,,8246131
3624.0,infected,patients,Northwest Sydney cluster,,,,,,,,yes,,,,,3335077
61.0,null,patients,H (normal lactobacilli-dominated microbiota),0.0,61.0,31.0,31.0,21.0,44.0,21-44,,,,,,9197028
15.0,bacterial vaginosis (BV),patients,BV,0.0,15.0,,,,,,,,,,,9197028
22.0,intermediate microbiota,patients,I,0.0,22.0,,,,,,,,,,,9197028
123.0,null,patients,first-year psychology undergraduates,31.0,92.0,19.86,19.0,17.0,52.0,17-52,,,,,,5933718
117.0,null,patients,adults from German cities,,,29.1,,17.0,65.0,17-65,,,,,,5933718
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,10984546
0.0,null,healthy,null,0.0,0.0,,,,,,,,,,,10984546
20.0,Oxygen-induced retinopathy (OIR) model,patients,C57BL/6 mice,,,,,,,,yes,,,,,3391198
5.0,HIV-1 gp120,patients,gp120 treatment,3.0,2.0,,,,,,,,,,,9124804
6.0,control,healthy,saline,5.0,1.0,,,,,,,,,,,9124804
5.0,HIV-1 gp120,patients,gp120 followed by rolipram,3.0,2.0,,,,,,,,,,,9124804
7.0,null,patients,L2/3 pyramidal neurones,,,,,,,null,yes,,,,,3137631
247.0,null,patients,null,94.0,153.0,27.3,,,,null,,,,,,4795763
20.0,homozygotes,patients,homozygotes,,,,,,,,yes,,,,,4511001
98.0,heterozygotes,patients,heterozygotes,,,,,,,,yes,,,,,4511001
89.0,wild type,patients,wild type,,,,,,,,yes,,,,,4511001
1.0,healthy,healthy,young,,,,,,,,yes,,,,,7929986
6.0,null,patients,Fisher rats,0.0,6.0,,,,,null,,,,,,4669183
50.0,healthy,healthy,students,19.0,31.0,25.06,25.0,18.0,39.0,18-39,,,,,,8599192
31.0,AD,patients,CSF biomarker-positive AD,,,,,,,,yes,,,,,6902042
16.0,MCI,patients,CSF biomarker-positive MCI,,,,,,,,yes,,,,,6902042
31.0,normal cognitively intact controls,healthy,cognitively intact biomarker-negative controls,,,,,,,,yes,,,,,6902042
20.0,null,healthy,students,6.0,14.0,22.6,22.0,19.0,26.0,19-26,,,,,,5298484
24.0,suicidal patients,patients,suicidal,,,,,,,,,,,,,5509773
21.0,non-suicidal patients,patients,non-suicidal,,,,,,,,,,,,,5509773
22.0,healthy controls,healthy,controls,,,,,,,,,,,,,5509773
12.0,none,patients,Mas-TRECK Tg mice,,,,,,,,,,,,,3184129
13.0,none,patients,Mas-TRECK Tg mice,,,,,,,,,,,,,3184129
6.0,none,patients,Mas-TRECK Tg mice,,,,,,,,,,,,,3184129
5.0,none,patients,Mas-TRECK Tg mice,,,,,,,,,,,,,3184129
36.0,leukemia/lymphoma,patients,Nalm-6,,,,,,,,,,,,,3767772
0.0,,healthy,MRI,,,,,,,,,,,,,7745967
10.0,null,patients,deionized water,,,,,,,null,no,,,,,11006189
10.0,null,patients,cola,,,,,,,null,no,,,,,11006189
10.0,null,patients,pomegranate juice,,,,,,,null,no,,,,,11006189
109.0,bipolar disorder,patients,bipolar disorder,,,39.0,,18.0,70.0,18-70,yes,,,,,9915674
79.0,control,healthy,comparison control,,,,,,,,yes,,,,,9915674
1210.0,none,patients,T. gondii tachyzoites,,,,,,,,yes,,,,,3081817
21.0,null,patients,expert mice,9.0,12.0,,,,,,,,,,,10501641
8.0,healthy,healthy,Healthy control,8.0,0.0,,,,,,,,,,,9365195
8.0,HCC-induced,patients,HCC-induced,8.0,0.0,,,,,,,,,,,9365195
5.0,none,healthy,line 6,0.0,5.0,15.0,15.0,15.0,15.0,15-15,yes,,,,,2254315
5.0,none,healthy,line 7,0.0,5.0,12.0,12.0,12.0,12.0,12-12,yes,,,,,2254315
38.0,,healthy,lisuride treatment,,,,,,,,,,,,,2797624
45.0,,healthy,"MDL 11,939 treatment",,,,,,,,,,,,,2797624
46.0,,healthy,raclopride treatment,,,,,,,,,,,,,2797624
50.0,,healthy,WAY-100635 treatment,,,,,,,,,,,,,2797624
47.0,,healthy,LSD treatment,,,,,,,,,,,,,2797624
46.0,,healthy,"MDL 11,939 LSD treatment",,,,,,,,,,,,,2797624
87.0,Alzheimers disease,patients,GSE5281,,,,,,,,yes,,,,,11135670
74.0,healthy controls,healthy,GSE5281,,,,,,,,yes,,,,,11135670
56.0,Alzheimers disease,patients,GSE122063,,,,,,,,yes,,,,,11135670
44.0,healthy controls,healthy,GSE122063,,,,,,,,yes,,,,,11135670
0.0,null,healthy,null,0.0,0.0,,,,,,,,,,,3827235
27.0,HIV-infected,patients,LATTE-2 trial participants,25.0,2.0,,,,,,yes,,,,,5755771
16.0,none,patients,C57BL/6J male mice,8.0,8.0,,,,,not specified,yes,,,,,4372440
18.0,naturally cycling women,patients,menstrual phase,0.0,18.0,,,,,,yes,,,,,3781309
25.0,men,healthy,hormonal contraceptives,25.0,0.0,,,,,,yes,,,,,3781309
25.0,women using hormonal contraceptives,patients,hormonal contraceptives,0.0,25.0,,,,,,yes,,,,,3781309
45.0,ASDs,patients,Modified Atkins diet,,,38.0,38.0,38.0,38.0,38,yes,,,,,10364988
37.0,cognitively healthy older adults,patients,older adults,18.0,19.0,71.0,71.0,60.0,86.0,60-86,yes,,,,,6927623
9.0,rda/rda mutant,patients,rda,,,,,,,,,,,,,3338648
8.0,rda/rda mutant,patients,rda,,,,,,,,,,,,,3338648
8.0,+ rda,healthy,+ rda,,,,,,,,,,,,,3338648
4.0,+ rda,healthy,+ rda,,,,,,,,,,,,,3338648
17.0,+ +,healthy,+ +,,,,,,,,,,,,,3338648
806.0,null,patients,null,,,,,,,,,,,,,10234566
359.0,null,healthy,university students,,,,,,,null,yes,,,,,10208514
58.0,sickle cell disease,patients,top-ranked manuscripts from NS countries,,,,,,,,,,,,,5315297
2.0,neutropenia complicating Rh incompatibility-induced hydrops fetalis,patients,top-ranked manuscripts from nNS countries,,,,,,,,,,,,,5315297
1.0,acute myeloid leukemia,patients,bottom-ranked manuscripts from NS countries,1.0,0.0,3.0,3.0,3.0,3.0,3-3,,,,,,5315297
1.0,Alexander's disease,patients,bottom-ranked manuscripts from NS countries,1.0,0.0,6.0,6.0,6.0,6.0,6-6,,,,,,5315297
1.0,combined deficiency of coagulant activity of the vitamin K-dependent factors,patients,bottom-ranked manuscripts from nNS countries,1.0,0.0,14.0,14.0,14.0,14.0,14-14,,,,,,5315297
52.0,advanced neuroblastoma,patients,bottom-ranked manuscripts from nNS countries,,,,,,,,,,,,,5315297
22.0,healthy,healthy,healthy subjects,,,,,,,,yes,,,,,5640224
139.0,glaucomatous,patients,glaucomatous patients,,,,,,,,yes,,,,,5640224
4.0,null,patients,female Wistar rats,0.0,4.0,,,,,null,yes,,,,,3699505
154.0,idiopathic RBD,patients,prodromal Parkinsons disease,,,,,,,,yes,,,,,6598638
102.0,healthy controls,healthy,age- and sex-matched controls,,,,,,,,yes,,,,,6598638
278.0,healthy young adults,healthy,young adults,,,20.41,20.0,18.0,25.0,18-25,yes,,,,,8903281
139.0,healthy older adults,healthy,older adults,,,64.63,64.0,55.0,75.0,55-75,yes,,,,,8903281
41.0,early-stage Parkinsons disease,patients,Parkinsons disease,,,68.28,68.0,60.0,75.0,60-75,yes,,,,,8903281
26.0,stable angina,patients,DCB,,,,,,,,yes,,,,,10721025
26.0,stable angina,patients,DES,,,,,,,,yes,,,,,10721025
10.0,Type 2 diabetes,patients,T2D rats,10.0,0.0,,,,,null,no,,,,,4420285
80.0,STGD1,patients,STGD1 patients,36.0,44.0,46.0,46.0,17.0,84.0,17-84,,,,,,8232401
182.0,PTMC,patients,PTMC patients,24.0,158.0,48.8,,,,N/A,yes,,,,,7775061
1016.0,breast cancer,patients,breast cancer patients,,,50.0,,,,null,yes,,,,,4091942
806.0,healthy,healthy,healthy controls,,,48.9,,,,null,yes,,,,,4091942
2819.0,Acute coronary syndrome (ACS),patients,CKD,2230.0,589.0,62.9,,,,unknown,yes,,,,,3756021
32.0,null,patients,young adults,16.0,16.0,23.41,23.0,18.0,30.0,18-30,,,,,,5490672
93.0,null,patients,introductory psychology students,22.0,71.0,22.02,,,,null,,,,,,5490672
55.0,ALS,patients,bulbar impairment,30.0,25.0,62.0,,29.0,89.0,29-89,yes,,,,,6698695
20.0,ASD,patients,ASD,,,,,7.0,15.0,7-15,yes,,,,,5939224
20.0,NT,healthy,NT,,,,,7.0,15.0,7-15,yes,,,,,5939224
56.0,HIV,patients,released from corrections,,,,,,,,yes,,,,,5809020
7.0,null,patients,ISS < 16,4.0,3.0,,59.0,18.0,84.0,18-84,,,,,,7790403
7.0,null,patients,ISS 16,4.0,3.0,,59.0,18.0,84.0,18-84,,,,,,7790403
3.0,null,patients,mild or moderate TBI,2.0,1.0,,59.0,18.0,84.0,18-84,,,,,,7790403
120.0,none,patients,male,120.0,0.0,,,,,,yes,,,,,8721142
15.0,neurologically intact,patients,right-handed volunteers,8.0,7.0,24.5,24.0,20.0,30.0,20-30,,,,,,10335960
57.0,null,patients,adult female SpragueDawley rats,0.0,57.0,2.0,2.0,2.0,2.0,2-2,yes,,,,,10885699
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,7906300
688.0,HIV positive,patients,Low Stable,,,,,,,,yes,,,,,7505419
688.0,HIV positive,patients,Low Increasing,,,,,,,,yes,,,,,7505419
688.0,HIV positive,patients,Moderate Stable,,,,,,,,yes,,,,,7505419
688.0,HIV positive,patients,High Increasing,,,,,,,,yes,,,,,7505419
152.0,null,patients,surgeons and anaesthetists,95.0,57.0,44.5,,,,null,yes,,,,,4103799
1.0,Leber hereditary optic neuropathy (LHON),patients,childhood-onset LHON,1.0,0.0,10.0,10.0,10.0,10.0,10-10,yes,,,,,5811516
36.0,lifelong PE,patients,LPE patients,36.0,0.0,,,,,,,,,,,8473781
23.0,normal controls,healthy,NCs,23.0,0.0,,,,,,,,,,,8473781
351.0,null,patients,school-age children,,,,,6.0,12.0,6-12,yes,,,,,8735612
20.0,null,patients,click dyads,10.0,10.0,24.757,,22.0,39.0,,yes,,,,,9232116
3.0,ovarian cancer,patients,A1847,0.0,3.0,,,,,,,,,,,3767807
3.0,ovarian cancer,patients,A2780,0.0,3.0,,,,,,,,,,,3767807
3.0,ovarian cancer,patients,OVCAR10,0.0,3.0,,,,,,,,,,,3767807
16.0,healthy,healthy,volunteers,8.0,8.0,27.0,27.0,27.0,28.0,27-28,yes,,,,,3461471
49.0,"no history of psychiatric, neurological or other medical illness",patients,English,19.0,30.0,21.3,21.0,18.0,30.0,18-30,,,,,,9424229
35.0,healthy,patients,Chinese,20.0,15.0,19.3,19.0,18.0,25.0,18-25,,,,,,9424229
28.0,healthy,patients,French,13.0,15.0,24.4,24.0,20.0,30.0,20-30,,,,,,9424229
173.0,null,patients,Manitoba,139.0,44.0,,,,,null,,,,,,3173445
56.0,null,patients,South Dakota,5.0,51.0,,,,,null,,,,,,3173445
44.0,null,patients,Kansas,20.0,24.0,,,,,null,,,,,,3173445
921.0,Type 2 diabetes,patients,empagliflozin,,,56.0,56.0,,,null,yes,,,,,9576049
921.0,Type 2 diabetes,patients,dapagliflozin,,,56.0,56.0,,,null,yes,,,,,9576049
1842.0,Type 2 diabetes,patients,DPP4i,,,57.0,57.0,,,null,yes,,,,,9576049
23.0,unfamiliar,patients,unfamiliar,10.0,13.0,22.02,22.0,18.0,29.0,,,,,,,7074657
22.0,familiar,healthy,familiar,9.0,13.0,,,,,,,,,,,7074657
2.0,null,patients,monkey F,1.0,0.0,,,,,,,,,,,6915702
2.0,null,patients,monkey J,1.0,0.0,,,,,,,,,,,6915702
31191.0,depressive symptoms,patients,NHANES,,,47.0,47.0,30.0,80.0,30-80,yes,,,,,6620014
5.0,Rett syndrome,patients,Mecp2 mice,5.0,0.0,18.0,18.0,18.0,18.0,18-18,yes,,,,,5559075
9.0,C. trachomatis,patients,Set 1,,,,,,,,,,,,,4074039
14.0,C. trachomatis,patients,Set 2,,,,,,,,,,,,,4074039
10.0,C. trachomatis,patients,Set 3,,,,,,,,,,,,,4074039
625.0,none,patients,SMC participants,625.0,0.0,,,,,,yes,,,,,4132017
4.0,normal and dystrophic,patients,dogs,2.0,2.0,,,,,adult,yes,,,,,3917863
20.0,tooth extraction,patients,non-administration,,,,,,,,,,,,,6028143
20.0,tooth extraction,patients,PLGA 100 mg control,,,,,,,,,,,,,6028143
20.0,tooth extraction,patients,SRLS 100 mg,,,,,,,,,,,,,6028143
20.0,tooth extraction,patients,SRLS 200 mg,,,,,,,,,,,,,6028143
20.0,tooth extraction,patients,SRLS 400 mg,,,,,,,,,,,,,6028143
54.0,bilateral severe to profound hearing loss,patients,cochlear implant candidates,31.0,23.0,5.2,5.0,0.0,17.0,0-17,,,,,,10544541
47.0,normal hearing,healthy,age- and sex-matched children,32.0,15.0,7.5,7.0,0.0,17.0,0-17,,,,,,10544541
585.0,AIBD,patients,AIBD,,,45.2,,2.0,100.0,2-100,no,,,,,8277047
53.0,eating disorder,patients,hypermobile,,,22.7,,,,null,,,,,,8790080
0.0,null,patients,VSMCs,0.0,0.0,,,,,,,,,,,5439712
23.0,healthy,patients,ME,0.0,23.0,21.2,,18.0,26.0,18-26,yes,,,,,4606127
17.0,healthy,patients,MH,0.0,17.0,20.9,,18.0,23.0,18-23,yes,,,,,4606127
15.0,healthy,patients,NM,0.0,15.0,21.6,,19.0,23.0,19-23,yes,,,,,4606127
0.0,null,patients,L929 cells,,,,,,,,,,,,,3585731
12.0,Hepatocellular carcinoma,patients,primary HCC tissues,,,,,,,,yes,,,,,3418236
11.0,colorectal cancer,patients,colon cancer,,,,,,,,yes,,,,,3418236
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,4401770
17.0,null,patients,mice,17.0,0.0,,,,,2-3 months,,,,,,7837117
4.0,null,patients,ACC imaging,4.0,0.0,,,,,null,,,,,,7837117
14.0,null,patients,two-step task ACC manipulation,8.0,6.0,,,,,null,,,,,,7837117
14.0,null,patients,probabilistic reversal learning task ACC manipulation,8.0,6.0,,,,,null,,,,,,7837117
900.0,null,patients,ADNI,,,,,55.0,90.0,55-90,yes,,,,,7308803
770.0,AD,patients,"ADNI1, ADNI2, ADNI-GO",,,,,,,null,yes,,,,,7308803
459.0,mild cognitive impairment,patients,"ADNI1, ADNI2, ADNI-GO",,,,,,,null,yes,,,,,7308803
262.0,nondemented/controls,healthy,"ADNI1, ADNI2, ADNI-GO",,,,,,,null,yes,,,,,7308803
204.0,AD,patients,UKBB,,,,,,,null,yes,,,,,7308803
316.0,null,patients,breastfed,171.0,145.0,3.2,3.0,3.0,4.0,3-3.5,yes,,,,,3254612
108.0,breast cancer,patients,breast cancer patients,,,,,,,,,,,,,3050918
100.0,healthy,healthy,healthy women,0.0,100.0,,,,,,,,,,,3050918
17.0,not specified,patients,preterm infants,,,,,,,,yes,,,,,9033282
54.0,healthy controls (HCs),healthy,HCs,,,,,,,,yes,,,,,7081773
31.0,microtia,patients,microtia patients,8.0,23.0,13.0,13.0,6.0,17.0,6-17,yes,,,,,8409618
198.0,COVID-19,patients,Facility A Residents,,,,,,,,no,,,,,7591018
49.0,M. nurag,patients,Mediterranean,0.0,49.0,,,,,,yes,,,,,4229126
54.0,M. jurtina,patients,Mediterranean,0.0,54.0,,,,,,yes,,,,,4229126
34.0,M. jurtina,patients,Central European,0.0,34.0,,,,,,yes,,,,,4229126
65.0,Alzheimers disease,patients,AD,65.0,0.0,,,,,,,,,,,9482276
48.0,Frontotemporal dementia,patients,FTD,,,,,,,,,,,,,9482276
20.0,Mild cognitive impairment,patients,MCI,,,,,,,,,,,,,9482276
13.0,Psychiatric disorders,patients,Psy,,,,,,,,,,,,,9482276
21.0,Healthy controls,healthy,Con,,,,,,,,,,,,,9482276
197.0,none,patients,higher risk,94.0,91.0,66.4,66.0,60.0,80.0,60-80,,,,,,5529958
197.0,none,patients,lower risk,,,,,,,,,,,,,5529958
168.0,Deficit Schizophrenia (DSZ),patients,DSZ,,,,,,,,,,,,,10827665
373.0,Non-Deficit Schizophrenia (NDSZ),patients,NDSZ,,,,,,,,,,,,,10827665
1019.0,Healthy Controls (HC),healthy,HC,,,,,,,,,,,,,10827665
575.0,Healthy Controls (HC),healthy,HC,,,,,,,,,,,,,10827665
1189090.0,dementia,patients,White,,,70.9,,65.0,100.0,65-100,yes,,,,,10566703
13082.0,dementia,patients,South Asian,,,69.4,,65.0,100.0,65-100,yes,,,,,10566703
9166.0,dementia,patients,Black,,,69.7,,65.0,100.0,65-100,yes,,,,,10566703
14.0,null,healthy,little brown myotis,14.0,0.0,,,,,null,yes,,,,,3290531
12.0,null,healthy,long-eared myotis,,,,,,,null,yes,,,,,3290531
7.0,null,healthy,fringed myotis,,,,,,,null,yes,,,,,3290531
4.0,null,healthy,Townsend's big-eared bats,,,,,,,null,yes,,,,,3290531
11.0,null,healthy,pallid bats,,,,,,,null,yes,,,,,3290531
59.0,uncomplicated malaria,patients,uncomplicated malaria,,,,,,,,yes,,,,,5705151
15.0,severe malaria,patients,severe malaria,,,,,,,,yes,,,,,5705151
10.0,healthy,healthy,C57BL/6J wild-type (WT),10.0,0.0,,,4.0,8.0,4-8 months,yes,,,,,4585492
5.0,epileptic,patients,Syn II knockout (Syn II),5.0,0.0,,,4.0,8.0,4-8 months,yes,,,,,4585492
34.0,MDD,patients,middle-aged and older adults,10.0,24.0,61.6,61.0,45.0,75.0,45-75,,,,,,8096948
0.0,,healthy,,,,,,,,,,,,,,8096948
16.0,EXT1 carriers,patients,EXT1 carriers,,,,,,,,yes,,,,,4277348
6.0,EXT2 carriers,patients,EXT2 carriers,,,,,,,,yes,,,,,4277348
26.0,non-carrier controls,healthy,non-carrier controls,,,,,,,,yes,,,,,4277348
9.0,mono-associated with the commensal species ZWU0020 of the genus Vibrio,patients,Vibrio,,,,,,,,,,,,,6292638
2.0,germ-free,patients,germ-free,,,,,,,,,,,,,6292638
1.0,mono-associated with Pseudomonas ZWU0006,patients,Pseudomonas,,,,,,,,,,,,,6292638
15.0,SNI,patients,male,15.0,0.0,,,6.0,8.0,6.5-8,yes,,,,,4111598
15.0,sham,patients,male,15.0,0.0,,,6.0,8.0,6.5-8,yes,,,,,4111598
10.0,SNI,patients,female,0.0,10.0,,,6.0,8.0,6.5-8,yes,,,,,4111598
11.0,sham,patients,female,0.0,11.0,,,6.0,8.0,6.5-8,yes,,,,,4111598
8.0,SNI,patients,male,8.0,0.0,,,6.0,8.0,6.5-8,yes,,,,,4111598
8.0,sham,patients,male,8.0,0.0,,,6.0,8.0,6.5-8,yes,,,,,4111598
5.0,SNI,patients,female,0.0,5.0,,,6.0,8.0,6.5-8,yes,,,,,4111598
6.0,sham,patients,female,0.0,6.0,,,6.0,8.0,6.5-8,yes,,,,,4111598
42.0,healthy,healthy,healthy participants,,,24.7,25.0,20.0,30.0,20-30,,,,,,9095461
23.0,cardioembolic stroke,patients,stroke,12.0,11.0,,,,,,,,,,,4103830
23.0,vascular risk factor controls,healthy,VRFC,12.0,11.0,,,,,,,,,,,4103830
0.0,null,patients,U251MG,,,,,,,null,,,,,,3827196
0.0,null,patients,U87MG,,,,,,,null,,,,,,3827196
0.0,null,patients,U118MG,,,,,,,null,,,,,,3827196
0.0,null,patients,T98G,,,,,,,null,,,,,,3827196
3.0,prion disease,patients,Tg(MHM223-88)/Prnp mice,2.0,1.0,,,538.0,730.0,538-730,yes,,,,,4199594
3.0,prion disease,patients,Tg(MHM223-88)/Prnp mice,2.0,1.0,,,347.0,393.0,347-393,yes,,,,,4199594
3.0,prion disease,patients,Prnp mice,2.0,1.0,,,469.0,496.0,469-496,yes,,,,,4199594
37.0,healthy controls,healthy,HC,23.0,14.0,38.3,,30.0,50.0,30-50,yes,,,,,9668609
18.0,drug-resistant TLE,patients,TLE,10.0,8.0,35.67,,25.0,50.0,25-50,yes,,,,,9668609
18.0,anti-AIV antibody positive,patients,yellow-legged gulls,0.0,18.0,,,,,,no,,,,,3348933
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,5104413
323.0,null,healthy,students,142.0,181.0,,,,,20-30,yes,,,,,6261539
20.0,COVID-19 related stress,patients,Veterans,17.0,3.0,54.2,54.0,28.0,72.0,28-72,,,,,,9754814
292.0,bTB suggestive histopathology,patients,cattle with bTB-like lesions,,,,,,,,,,,,,6261039
81.0,control population,healthy,cattle without bTB-like lesions,,,,,,,,,,,,,6261039
2567.0,HIV-infected adults with invasive pneumococcal disease,patients,overall,799.0,1033.0,37.7,37.0,18.0,64.0,,,,,,,3225377
7.0,null,patients,null,6.0,4.0,,,17.0,35.0,17-35,yes,,,,,3797963
0.0,null,patients,null,0.0,0.0,,,,,null,,,,,,3537769
0.0,null,healthy,null,0.0,0.0,,,,,null,,,,,,3537769
0.0,null,patients,null,,,,,,,null,,,,,,9067309
0.0,null,healthy,null,,,,,,,null,,,,,,9067309
39462.0,null,patients,women of reproductive age,0.0,39462.0,,,18.0,44.0,18-44,no,,,,,7728245
49.0,SCC,patients,HNSCC,,,,,,,,yes,,,,,5760229
65.0,diabetic nephropathy,patients,cases,,,,,,,,yes,,,,,2958112
83.0,no diabetic nephropathy,healthy,controls,,,,,,,,yes,,,,,2958112
9.0,Parkinson disease,patients,C57BL/6 wild-type mice,,,,,,,46 months,yes,,,,,7991918
3.0,Parkinson disease,patients,LSNTD1,,,,,,,1 day,yes,,,,,7991918
3.0,Parkinson disease,patients,LSNTD7,,,,,,,7 days,yes,,,,,7991918
3.0,Parkinson disease,patients,SHAM,,,,,,,7 days,yes,,,,,7991918
2941.0,null,patients,network condition,,,,,,,null,yes,,,,,10401006
11.0,null,patients,Mongolian gerbils,11.0,0.0,,,10.0,12.0,10-12 weeks,yes,,,,,6532536
7.0,glioma,patients,survivors,7.0,0.0,,,,,,,,,,,6907781
6.0,glioma,patients,deceased,6.0,0.0,,,,,,,,,,,6907781
12.0,glioma,patients,controls,,,,,,,,,,,,,6907781
0.0,null,patients,null,0.0,0.0,,,,,null,,,,,,5996106
0.0,null,healthy,null,0.0,0.0,,,,,null,,,,,,5996106
12.0,healthy,healthy,older adults,7.0,5.0,67.5,,66.0,77.0,66-77,yes,,,,,8276699
11.0,healthy,healthy,younger adults,6.0,5.0,22.5,,20.0,25.0,20-25,yes,,,,,8276699
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,2814856
0.0,null,healthy,null,0.0,0.0,,,,,,,,,,,2814856
80.0,none,patients,Wistar rats,80.0,0.0,6.0,6.0,6.0,6.0,6-6,yes,,,,,9459164
98.0,Basal-like,patients,TCGA,,,,,,,,,,,,,8221501
199.0,Basal-like,patients,METABRIC,,,,,,,,,,,,,8221501
38.0,healthy,healthy,adults,22.0,9.0,31.258,31.0,22.0,57.0,22-57,,,,,,9349214
31.0,healthy,healthy,EEG participants,22.0,9.0,31.258,31.0,22.0,57.0,22-57,,,,,,9349214
2.0,osteosarcoma,patients,Saos-2 cells,1.0,1.0,,,,,,,,,,,3942417
2.0,osteosarcoma,patients,MG63 cells,1.0,1.0,,,,,,,,,,,3942417
162.0,MDR-TB,patients,MDR-TB patients,105.0,57.0,34.0,34.0,29.0,42.0,29-42,yes,,,,,3983205
150.0,null,patients,undergraduate and graduate students,,,21.0,21.0,20.0,21.0,20-21,yes,,,,,7743924
25.0,stroke with dysphagia,patients,electroacupuncture group,,,,,,,,yes,,,,,10656700
25.0,stroke with dysphagia,patients,control group,,,,,,,,yes,,,,,10656700
304.0,null,patients,Italian community-dwelling adults,74.0,230.0,35.28,,18.0,78.0,18-78,no,,,,,7834264
418.0,null,patients,EMA study participants,,,25.07,,17.0,63.0,17-63,yes,,,,,7235964
15.0,healthy,healthy,Experiment 1,8.0,7.0,29.0,29.0,21.0,51.0,21-51,yes,,,,,4478379
15.0,healthy,healthy,Experiment 2,6.0,9.0,26.0,26.0,20.0,49.0,20-49,yes,,,,,4478379
12.0,auditory processing complaints,patients,LEA,10.0,2.0,10.9,10.0,7.0,14.0,7-14,,,,,,4128035
12.0,typical development,healthy,REA,10.0,2.0,10.9,10.0,7.0,14.0,7-14,,,,,,4128035
272.0,scoliosis,patients,AIS,,,,,,,,,,,,,8699618
26.0,healthy,healthy,healthy,,,,,,,,,,,,,8699618
0.0,null,patients,Colo829,,,,,,,null,,,,,,8785960
0.0,null,patients,A375,,,,,,,null,,,,,,8785960
0.0,null,patients,WM-266.4,,,,,,,null,,,,,,8785960
0.0,null,patients,A549,,,,,,,null,,,,,,8785960
0.0,null,patients,PC-3,,,,,,,null,,,,,,8785960
0.0,null,patients,DU145,,,,,,,null,,,,,,8785960
5055.0,hypertension,patients,hypertensive patients,,,,,,,,no,,,,,5739392
4163.0,null,patients,elderly,2030.0,2133.0,,,60.0,103.0,60-103,yes,,,,,9879507
13000.0,HIV-1 positive,patients,INSTI,9750.0,3250.0,48.0,48.0,18.0,70.0,35-54,yes,,,,,7774984
92.0,breast cancer,patients,breast cancer patients,,,,,,,,yes,,,,,3282723
1.0,null,patients,guinea pigs,1.0,0.0,,500.0,500.0,500.0,500,yes,,,,,6691069
87.0,acquired language impairment due to brain damage,patients,language-impaired cohort,64.0,23.0,61.9,61.0,23.0,82.0,23-82,,,,,,9677348
38.0,neurotypical adults,healthy,control group,13.0,25.0,,,,,,,,,,,9677348
155.0,null,patients,HEXACO-60,76.0,275.0,23.4,,,,null,yes,,,,,3931641
6.0,CsA treatment,patients,KAP Tg mice,6.0,0.0,,,,,,,,,,,3182248
1.0,synesthete,patients,N.W.,0.0,1.0,24.0,24.0,24.0,24.0,24-24,yes,,,,,4867783
15.0,non-synesthetic controls,healthy,controls,4.0,11.0,24.2,24.0,22.0,26.0,22-26,yes,,,,,4867783
40.0,healthy,healthy,total,20.0,20.0,23.0,23.0,20.0,30.0,20-30,,,,,,8545051
20.0,healthy,healthy,test-retest,10.0,10.0,23.0,23.0,20.0,30.0,20-30,,,,,,8545051
40.0,diabetes,patients,db/db,40.0,0.0,5.0,5.0,5.0,5.0,5-5,yes,,,,,5443478
40.0,healthy,healthy,db/+,40.0,0.0,5.0,5.0,5.0,5.0,5-5,yes,,,,,5443478
2.0,null,patients,C57BL/6J male mice,2.0,0.0,,,,,null,yes,,,,,2533699
285.0,type 1 diabetes,patients,CSII>12 months,,,16.6,,12.0,20.0,12-20,yes,,,,,4822832
704.0,type 1 diabetes,patients,MDI>12 months,,,17.1,,12.0,20.0,12-20,yes,,,,,4822832
15.0,deaf,patients,DE (deaf early),6.0,9.0,,,,,,yes,,,,,7985620
11.0,deaf,patients,DL (deaf late),5.0,6.0,,,,,,yes,,,,,7985620
14.0,hearing,healthy,HE (hearing early),2.0,12.0,,,,,,yes,,,,,7985620
12.0,hearing,healthy,HL (hearing late),6.0,6.0,,,,,,yes,,,,,7985620
0.0,null,patients,T cell leukemia,,,,,,,null,,,,,,3958508
0.0,null,healthy,PBMC,,,,,,,null,,,,,,3958508
16.0,null,patients,Long-Evans male,16.0,0.0,,,11.0,16.0,11-16,yes,,,,,9187087
16.0,null,patients,Long-Evans female,0.0,16.0,,,11.0,16.0,11-16,yes,,,,,9187087
16.0,null,patients,Wistar male,16.0,0.0,,,11.0,16.0,11-16,yes,,,,,9187087
16.0,null,patients,Wistar female,0.0,16.0,,,11.0,16.0,11-16,yes,,,,,9187087
90.0,psychosis risk,patients,discovery sample,,,,,,,,yes,,,,,6581147
211.0,maternal smoking effects,patients,replication sample,,,,,,,,yes,,,,,6581147
48.0,normal or corrected-to-normal vision,healthy,undergraduate students,18.0,30.0,18.88,19.0,18.0,19.0,18-19,yes,,,,,8102837
52.0,normal or corrected-to-normal vision,healthy,undergraduate students,16.0,36.0,18.846,23.0,18.0,31.0,18-31,yes,,,,,8102837
6.0,normoxia,healthy,C57BL/6 wild type time-mated females,0.0,6.0,,,,,,,,,,,7034911
6.0,hypoxia,healthy,C57BL/6 wild type time-mated females,0.0,6.0,,,,,,,,,,,7034911
4.0,normoxia,healthy,C57BL/6 wild type time-mated females,4.0,0.0,7.0,7.0,7.0,7.0,,,,,,,7034911
8.0,hypoxia,healthy,C57BL/6 wild type time-mated females,8.0,0.0,7.0,7.0,7.0,7.0,,,,,,,7034911
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,7771676
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,3084762
1304.0,cis-heterosexual individuals,healthy,cis-heterosexual,495.0,809.0,,,,,,no,,,,,8186787
832.0,individuals with minoritized sexual identities,patients,minoritized sexual identities,,,,,,,,no,,,,,8186787
197.0,individuals with minoritized gender identities,patients,minoritized gender identities,,,,,,,,no,,,,,8186787
249.0,acne,patients,self-reported acne,115.0,134.0,,,,,,no,,,,,8049225
39.0,EAE,patients,C57Bl/6 mice with EAE,,,,,,,,,,,,,4352054
7.0,none,patients,L71.8TG mice (vehicle),,,,,,,,,,,,,4352054
6.0,none,patients,L71.8TG mice (PF-01247324),,,,,,,,,,,,,4352054
8.0,none,healthy,wildtype littermates (vehicle),,,,,,,,,,,,,4352054
37.0,null,patients,mothers,0.0,37.0,31.16,31.0,20.0,43.0,20-43,,,,,,6007508
16.0,null,patients,primiparous mothers,0.0,16.0,,,,,,,,,,,6007508
21.0,null,patients,multiparous mothers,0.0,21.0,,,,,,,,,,,6007508
3.0,active TB,patients,seniors,1.0,2.0,73.0,73.0,65.0,81.0,65-81,yes,,,,,6438508
61.0,severe and non-severe pneumonia,patients,severe,33.0,28.0,63.0,,48.0,78.0,48-78,,,,,,8136668
61.0,severe and non-severe pneumonia,patients,non-severe,,,,,,,,,,,,,8136668
12.0,Trpv4,patients,Trpv4,12.0,0.0,,,,,,,,,,,7235376
12.0,WT,patients,WT,11.0,1.0,,,,,,,,,,,7235376
200.0,severe congenital ptosis,patients,FM flap advancement surgery,111.0,89.0,7.4,7.0,2.0,16.0,2-16,,,,,,7853494
521.0,skull base neoplasms,patients,all patients,283.0,238.0,54.3,,17.0,86.0,17-86,yes,,,,,7959384
0.0,,healthy,Pnmt-Cre ROSA26,0.0,0.0,,,,,,,,,,,3144959
4.0,none,patients,autopsy cases,4.0,0.0,,,20.0,75.0,20-75,no,,,,,4175995
29.0,hypertension,patients,hypertensive,,,,,,,,,,,,,3154930
29.0,normotension,patients,normotensive,,,,,,,,,,,,,3154930
97.0,null,patients,participants,32.0,64.0,19.9,19.0,17.0,42.0,17-42,,,,,,7743977
0.0,null,healthy,null,,,,,,,,,,,,,7743977
8.0,null,patients,cadaveric study,4.0,4.0,56.0,56.0,44.0,68.0,44-68,no,,,,,6193610
3912.0,POP,patients,before DRG,,,,,,,,,,,,,6701833
3450.0,POP,patients,after DRG,,,,,,,,,,,,,6701833
2194.0,MDE,patients,MDE,1465.0,729.0,19.2,19.0,18.0,22.0,18-22,yes,,,,,6053211
30.0,breast cancer,patients,MRI,0.0,30.0,55.0,55.0,45.0,65.0,45-65,,,,,,2674775
1273.0,primary PPH,patients,IPI <24 months,0.0,1273.0,27.1,27.0,21.0,35.0,21-35,,,,,,9292068
1305.0,no primary PPH,healthy,IPI 24-60 months,0.0,1305.0,27.5,27.0,21.0,35.0,21-35,,,,,,9292068
0.0,null,patients,S1pr2,,,,,,,,,,,,,5962071
3.0,null,patients,axolotls,2.0,1.0,16.0,16.0,16.0,16.0,16-16,yes,,,,,5570274
93.0,red-green congenital colour vision deficiencies,patients,colour vision deficient,90.0,3.0,30.4,30.0,18.0,59.0,18-59,yes,,,,,4839569
127.0,normal trichromats,healthy,control,79.0,48.0,29.3,29.0,17.0,60.0,17-60,yes,,,,,4839569
91.0,red-green congenital colour vision deficiencies,patients,colour vision deficient,88.0,3.0,30.5,30.0,18.0,59.0,18-59,yes,,,,,4839569
47.0,red-green congenital colour vision deficiencies,patients,colour vision deficient,47.0,0.0,31.8,32.0,18.0,59.0,18-59,yes,,,,,4839569
0.0,null,patients,null,0.0,0.0,,,,,null,no,,,,,4294125
0.0,null,patients,PC3 cells,,,,,,,,no,,,,,3525640
24.0,none,patients,Proprioceptive training with feedback (PTWF),,,,,,,,,,,,,8975733
24.0,none,patients,Proprioceptive training no feedback (PTNF),,,,,,,,,,,,,8975733
24.0,none,patients,Control (CTRL),,,,,,,,,,,,,8975733
135.0,HBOC,patients,BRCA1 and BRCA2 germline variants,,,,,,,,yes,,,,,7799847
18410.0,postoperative delirium,patients,elderly,,,,,,,,yes,,,,,10346854
335.0,healthy,healthy,prosaccade,,,,,,,,yes,,,,,5434188
364.0,healthy,healthy,word reading,,,,,,,,yes,,,,,5434188
28.0,healthy,healthy,patients undergoing sinonasal surgery,18.0,10.0,46.6,,18.0,66.0,18-66,yes,,,,,3875580
291.0,AD,patients,AD,,,,,,,,,,,,,4529880
90.0,MCI converters,patients,MCI converters,,,,,,,,,,,,,4529880
357.0,stable MCI,patients,stable MCI,,,,,,,,,,,,,4529880
331.0,HC,healthy,HC,,,,,,,,,,,,,4529880
10.0,normal,healthy,observers,5.0,5.0,,,,,,,,,,,10369874
0.0,null,patients,null,,,,,,,,,,,,,4047101
0.0,,healthy,Diversispora epigaea,,,,,,,,,,,,,3154914
0.0,,healthy,Glomus versiforme,,,,,,,,,,,,,3154914
811.0,H. pylori infection,patients,H. pylori positive,251.0,560.0,59.2,,,,null,no,,,,,4447445
2533.0,null,patients,young women,0.0,2533.0,15.0,15.0,13.0,20.0,13-20,yes,,,,,6336295
12.0,healthy,healthy,WT mice,12.0,0.0,,,,,P56,yes,,,,,5049801
9.0,patients,patients,Rbfox3 mice,9.0,0.0,,,,,P56,yes,,,,,5049801
8.0,healthy,healthy,WT mice,8.0,0.0,,,,,P56,yes,,,,,5049801
8.0,patients,patients,Rbfox3 mice,8.0,0.0,,,,,P56,yes,,,,,5049801
0.0,null,patients,null,0.0,0.0,,,,,null,no,,,,,9075657
26.0,HIV-positive with tuberculosis (TB),patients,hospital workers,,,,,,,,yes,,,,,3925080
5522.0,null,patients,Wave 3 ITC BD Survey,,,,,,,null,yes,,,,,4090160
0.0,null,healthy,normal donors,,,,,,,,,,,,,7689020
23.0,tinnitus patients,patients,tinnitus patients,,,,,23.0,66.0,23-66,yes,,,,,3319920
21.0,controls,healthy,controls,,,,,27.0,67.0,27-67,yes,,,,,3319920
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,3940443
8.0,normal,healthy,Pla,,,,,,,,yes,,,,,5321410
5891.0,nave T cells,patients,C57Bl/6,,,,,,,,yes,,,,,4798282
21.0,mildly-affected SAH,patients,mildly-affected SAH,,,,,,,,,,,,,3946189
12.0,severely-affected SAH,patients,severely-affected SAH,,,,,,,,,,,,,3946189
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,7524009
0.0,null,healthy,null,0.0,0.0,,,,,,,,,,,7524009
146.0,null,patients,Wistar neonate rats,73.0,73.0,,,,,,,,,,,5359529
99.0,null,patients,German-French bilinguals,,,,,,,null,yes,,,,,9423630
22.0,non-clinical,healthy,non-clinical volunteers,,,,,,,,yes,,,,,6475651
16.0,null,patients,adult female green turtles,0.0,16.0,,,,,null,,,,,,4580322
12.0,none,healthy,physically active men,12.0,0.0,21.9,22.0,21.0,24.0,21-24,,,,,,6548427
0.0,null,patients,null,0.0,0.0,,,,,,,,,,,4723304
20.0,arrhythmogenic cardiomyopathy,patients,LMNA mutation carriers,10.0,10.0,,,12.0,58.0,,yes,,,12.0,58.0,4383583
67.0,FTD,patients,C9+,,,,,,,,,,,,,6535128
56.0,FTD,patients,C9-,,,,,,,,,,,,,6535128
27.0,healthy,healthy,controls,,,,,,,,,,,,,6535128
233.0,null,patients,intervention,119.0,114.0,25.0,25.0,18.0,40.0,,,,,,,4890862
233.0,null,patients,control,41.0,42.0,26.0,26.0,19.0,39.0,,,,,,,4890862
15.0,ADHD,patients,ADHD,8.0,7.0,15.3,15.0,12.0,18.0,12-18,,,,,,9077889
57.0,ASD,patients,ASD,43.0,14.0,13.7,13.0,9.0,18.0,9-18,,,,,,9077889
5.0,control,healthy,Control fish,,,,,,,,yes,,,,,3688944
5.0,exposure to brackish water,healthy,Experimental fish,,,,,,,,yes,,,,,3688944
14.0,null,patients,undergraduate students,8.0,6.0,20.0,20.0,19.0,22.0,19-22,,,,,,5602348
7.0,obesity,patients,high-fat diet,0.0,7.0,6.0,6.0,6.0,6.0,6-6,yes,,,,,3843710
0.0,null,patients,null,,,,,,,,,,,,,10723708
723.0,critically ill patients,patients,ICU admissions,444.0,279.0,53.0,53.0,39.0,69.0,39-69,yes,,,,,7365402
0.0,,healthy,DRG cells,,,,,,,,yes,,,,,4196919
80.0,HIV-infected PWID,patients,HHRP+,,,,,,,,,,,,,4320073
80.0,HIV-infected PWID,patients,3H+,,,,,,,,,,,,,4320073
20.0,null,patients,pygmy rabbits,,,,,,,null,yes,,,,,5354270
861.0,Alzheimer's Disease,patients,AD patients,,,,,70.0,80.0,70-80,yes,,,,,10533929
5204.0,head and neck cancer,patients,case group,,,,,,,,yes,,,,,3747175
5518.0,head and neck cancer,healthy,control group,,,,,,,,yes,,,,,3747175
12.0,healthy,healthy,young participants,6.0,6.0,30.34,30.0,24.0,36.0,24-36,,,,,,5984391
0.0,,healthy,,,,,,,,,,,,,,5984391
